Blood Shortage Reduction by Deployment of Lateral Transshipment Approach by Emadi, Parmis
University of Windsor 
Scholarship at UWindsor 
Electronic Theses and Dissertations Theses, Dissertations, and Major Papers 
5-21-2020 
Blood Shortage Reduction by Deployment of Lateral 
Transshipment Approach 
Parmis Emadi 
University of Windsor 
Follow this and additional works at: https://scholar.uwindsor.ca/etd 
Recommended Citation 
Emadi, Parmis, "Blood Shortage Reduction by Deployment of Lateral Transshipment Approach" (2020). 
Electronic Theses and Dissertations. 8332. 
https://scholar.uwindsor.ca/etd/8332 
This online database contains the full-text of PhD dissertations and Masters’ theses of University of Windsor 
students from 1954 forward. These documents are made available for personal study and research purposes only, 
in accordance with the Canadian Copyright Act and the Creative Commons license—CC BY-NC-ND (Attribution, 
Non-Commercial, No Derivative Works). Under this license, works must always be attributed to the copyright holder 
(original author), cannot be used for any commercial purposes, and may not be altered. Any other use would 
require the permission of the copyright holder. Students may inquire about withdrawing their dissertation and/or 
thesis from this database. For additional inquiries, please contact the repository administrator via email 
(scholarship@uwindsor.ca) or by telephone at 519-253-3000ext. 3208. 
 
 
Blood Shortage Reduction by Deployment of Lateral Transshipment Approach 
By 
Parmis Emadi 
A Thesis  
Submitted to the Faculty of Graduate Studies  
through the Department of Mechanical, Automotive & Materials Engineering 
in Partial Fulfillment of the Requirements for 
the Degree of Master of Applied Science 
 at the University of Windsor 
 




© 2020 Parmis Emadi 






M. Freeman  










Z. Pasek, Advisor 











DECLARATION OF ORIGINALITY 
I hereby certify that I am the sole author of this thesis and that no part of this thesis has 
been published or submitted for publication. 
I certify that, to the best of my knowledge, my thesis does not infringe upon anyone’s 
copyright nor violate any proprietary rights and that any ideas, techniques, quotations, or any other 
material from the work of other people included in my thesis, published or otherwise, are fully 
acknowledged in accordance with the standard referencing practices. Furthermore, to the extent 
that I have included copyrighted material that surpasses the bounds of fair dealing within the 
meaning of the Canada Copyright Act, I certify that I have obtained a written permission from the 
copyright owner(s) to include such material(s) in my thesis and have included copies of such 
copyright clearances to my appendix.  
I declare that this is a true copy of my thesis, including any final revisions, as approved by 
my thesis committee and the Graduate Studies office, and that this thesis has not been submitted 






The healing effects of human blood make it one of the essential, life-saving components in a 
variety of medical procedures. However, assuring timely and sufficient blood supply for use in 
life-critical medical procedures is one of the major challenges that most health care networks 
around the world are persistently facing and trying to resolve. Based on the WHO’s latest statistics, 
107 out of 180 countries all around the world have an insufficient amount of blood units to meet 
their demands. For two years in the row (2018-19), Canadian Blood Services have called for 
100,000 new donors to sign up in order to meet the anticipated demand for blood. The perishability 
of blood components and uncertainty in both donation and demand scale are two important reasons 
that contribute to the blood shortage. Due to the poor inventory planning, the high rate of discarded 
units is another worldwide issue that exists in the blood supply chain and needs to be urgently 
addressed.  
Canadian blood supply chain network consists of several organizational entities and each of them 
impacts the blood units’ inventory levels in its own, unique way. In this study, an integrated supply 
chain model has been considered, and it consists of three main networked organizations: 1. Mobile 
Collection Centers, 2. Blood Centers, and 3. Hospitals. The main goal of this research is to develop 
a mathematical optimization model that can improve the proposed supply chain’s performance by 
reducing its related costs, and the currently existing shortage rate from about 25% to less than 
15%. Lateral Transshipment and Emergency Ordering are two main approaches that have been 
implemented in the proposed model in order to improve both performance and efficiency.  
The Greater Toronto Area (GTA) has been considered as the case study focus for this research, 
and both models have been applied in this case study. All the further necessary actions and 
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1.1. Background & Motivation 
Managing blood supply chain network has always been crucial for governments and organizations 
due to the blood’s characteristics. Perishability of blood products, uncertainty in donation and 
demand sizes are the three main reasons that complicate the blood supply chain planning (National 
Health Expenditure Trends, 2018).  
The most important reason is that blood is a perishable product and consists of various components 
each with different expiring dates. Therefore, all the needed actions should be taken in the shortest 
possible time in order to both save blood components from expiration and avoid having any blood 
discarding related costs. Based on the latest Canadian Blood Services (CBS) annual review, it has 
been realized that the rate of whole blood discards during the year 2017-2018 was almost near to 
6% of the total blood donations (Year-End Review, CBS). Having a precise plan, which controls 
the flow of blood donations in a system, helps to reduce wasted units and their costs. 
Hitherto only few substitutes have been introduced for blood products and humans are the main 
resource for supplying these component. Due to the fact that donation process deals with high 
uncertainty, these components are categorized as scarce products that are at risk of serious 
shortages. Various factors can affect the blood shortage issue:  
- The number of donors who are willing to donate regularly. 




- The blood services ability to adequately predict the number of units of blood required 
throughout the year 
- The clinicians’ awareness of appropriate blood ordering and transfusion and the hospital 
laboratories ability to ensure sufficient stock (Chargé, 2019).  
For instance, based on the statistics, there are seasonal shortages due to low blood donations during 
the winter and summer months (Annual Report, 2015; Glicher & McCombs, 2005).  
Patients are the final customers of a blood supply chain network, and blood components are in a 
direct relation with human lives. These products are one of the main participants of organ 
transplants, cancer and anemia treatments, and major surgeries such as, for example open-heart 
surgery. So, it can be figured out that the request for blood by the patients drives the supply chain 
and determines the number of required blood donations (Chargé, 2019). However, since blood is 
a single-source product, in many countries, people still die because of inadequate supply of blood 
products (World Health Organization, 2012).  Any shortage of these components can have serious 
consequences such as increasing the mortality rate especially in the time-sensitive situations. 
Having a precise plan can help to match the blood supplied and demands with each other.  
A precise plan manages both inventory level and inventory flow in a way that not only improves 
the performance of the blood supply chain, but does it also have a significant impact on reducing 
the costs of the blood supply chain or generally the healthcare industry. Due to the latest statistics, 
healthcare spending in Canada is projected to reach $264.4 billion in 2019, representing 11.6% of 
Canada’s gross domestic product (GDP). This amounts to $7,068 per Canadian. Figure 1.1 shows 
total health expenditure costs have grown 45 years in Canada (National Health Expenditure 





Figure 1.1- Total Health Expenditure Growth (National Health Expenditure Database, Canadian Institute 
for Health Information) 
Besides the complex characteristic of blood components, the high global dependency on the US 
for applying blood product such as source platelets is another international concern about blood 
supply chain planning that is growing these days. According the latest statistics available, in 2016, 
Canada paid the US 512 million dollars to provide various types of blood components (Dinerstein, 
2018). Hence, besides life-threatening problems, shortage raises concern about additional costs 
that governments have to pay if they cannot satisfy patients’ demands by using their own blood 
collection resources.  
In conclusion, the required actions to face blood shortage issue can be varied considering the 
existing shortage level in a blood supply chain system. (Daniel and Contreras, 2005). As an 
example, in August 2018, Canadian Blood Services was faced with a serious shortage issue. In an 




be able to deal with the shortage issue (Global News, 2018). Moreover, in March 2020, Canadian 
Blood Services Organization reported 20 percent dropped in the number of donations due to the 
COVID-19 pandemic resulted in a blood shortage issue (The Canadian Press, 2020). 
1.2. Canadian Blood Supply Chain Configuration 
A supply chain is the network of organizations that are involved, through upstream and 
downstream linkages, in the various processes and activities that produce value in the form of 
products and services delivered to the ultimate consumer (Christopher, 2016). In other words, a 
supply chain consists of multiple firms, both upstream (i.e., supply) and downstream (i.e., 
distribution), and the ultimate consumer (Mentzer et al, 2001). 
Performance is one of the factors to measure how much the supply chain is well-organized. Supply 
Chain Network Design (SCND) is one type of strategic decision methods that are used to improve 
the supply chain’s performance. Generally, SCND consists of determining the optimal numbers, 
locations, and capacities of the required facilities and the aggregated material flows among them 
over a long and multi-period planning horizon (Zahiri et al, 2015). In addition, both shortage and 
surplus of a blood supply can cause serious problems such as an increase in the mortality rate or 
supply chain’s costs (Kuruppu, 2010). Therefore, understanding the configuration of the intended 
supply chain will help to identify the existing opportunities that are useful for improving the supply 
chain’s performance. 
Canadian blood supply chain is a framework in which blood components collected from donors 
across Canada are delivered to the patients who are in need. Figure 1.2 shows the supply chain 






Figure 1.2- CBS Supply Chain (Chargé, 2019) 
1.2.1. Donors 
Since humans are the only source of the blood, blood donors can be considered as the main actor 
of the Canadian blood supply chain. The donor’s suitability for donating blood is one of the 
greatest concerns in every blood supply chain. As stated in the World Health Organization’s 
guidelines, “Blood transfusion services have the responsibility to collect blood only from donors 
who are at low risk for any infection that could be transmitted through transfusion and who are 
unlikely to jeopardize their own health by blood donation” (Public Health Agency of Canada, 
2019). Blood operators have to follow the standard procedure provided for them in a way they can 
screen which donors are eligible for donating blood components. The standard procedure consists 
of several steps such as, for example donor questionnaires and required tests. The donor 
questionnaire includes several essential questions that should be answered by the donors. It should 
be noted donors should be completely honest during this process, and let operators know about 
any of their health hazards that may affect the safety of the blood components. Moreover, the 
required tests are conducted in a way that will notify the operators of the presence of any known 
transfusion-transmissible infectious (Blake and Hardy, 2014). If blood satisfies all the 
requirements regarding its safety, compatibility will be the next factor that makes the use of this 




each other. As has been shown in Figure 1.3, recipients with blood type AB+ can receive blood 
from all other types, while recipients with blood type O- can only receive blood from the same 
blood type. On the other hand, blood donation type AB+ can only be transfused to the patients 
with blood type AB+, while blood donation type O- can be transfused to patients with any blood 
type. 
 
Figure 1.3- Blood Types Compatibility (World Health Organization, 2012) 
Moreover, Figure 1.4 shows the breakdown of blood types in Canadian population.  
 




As has been shown in Figure 1.4, some blood types (e.g. AB-, and B-) are more at risk of shortage 
than the others. 
Ageing population phenomenon is another concern that is related to the donors. It has been 
estimated the blood components’ demands will increase more than 10 % over the next decade 
while the number of available donors will most likely be reduced (Ghandforoush and Sen, 2010). 
1.2.2. Canadian Blood Services(CBS) 
There are two blood operators in Canada: Héma-Québec, serving hospitals in the province of 
Québec, and Canadian Blood Services, serving hospitals in all provinces and territories outside of 
Québec. Canadian Blood Services is incorporated as a not-for-profit organization. It is regulated 
as a biologics manufacturer by Health Canada and primarily funded by the provincial and territorial 
ministries of health, except Québec. The ministers of health appoint Canadian Blood Services’ 
board of directors, approve Canadian Blood Services’ annual budget and review its corporate plan. 
With its head office in Ottawa, Canadian Blood Services manages manufacturing sites, testing 
facilities and collection sites across Canada (except Québec) from both operations and quality 
assurance perspective. All sites undergo regular and extensive internal and external audits. CBS 
organization is responsible primarily for preparing fresh blood components from volunteer 
donations and managing their supply to hospitals for patients in need. As part of this responsibility, 
the blood operators select donors, collect and test donated blood, process donated blood into blood 
components, and store and transport blood components and products to hospitals. Qualified 
personnel with a wide range of skills and expertise (e.g. medical, nurses, laboratory technologists, 
regulatory, legal, finance, IT), supported by an extensive quality system and an appropriate 




and Hardy, 2014). CBS has a specific inventory level for each blood component. Based on the 
available blood component, the inventory level would be determined. For instance, platelet which 
is the rarest component of blood can have 3 main inventory levels’ phase: 1. Green, 2. Amber and 
3. Red. Table 1.1 defines each of these inventory level phases. 
 Table 1.1- Platelets Inventory Level (CBS Report, 2016) 
Platelet Inventory Level % of National Requirement 
Green Phase (Minimal decrease to optimal) 80-100% of Daily National Requirement 
Amber Phase (Serious) 25-79% of Daily National Requirement 
Red Phase (Critical) <25% of Daily National Requirement 
Although Canada is one the main blood buyers from the US, and CBS invite more people to donate 
their blood components, based on the existing information, during the latest years, the inventory 
level of platelets in in the CBS is in the Amber phase which indicates that at least 20% and at most 
75% of demands would not be satisfied (Dinerstein, 2018). On the other hand, Figure 1.5 shows 
that in April 2018, more than 10% of collected platelets have been discarded. Considering all these 
existing facts reveals that CBS is facing a serious management problem, and it needs an integrated 





Figure 1.5- CBS Platelet Outdated Units’ Issue (CBS Annual Report, 2018) 
1.2.3. Hospitals 
After collecting the blood components, CBS centers will send them to hospitals. Hospitals are the 
penultimate stage in the Canadian supply chain, and they are responsible for safe transfusion of 
the blood components to the patients. Although various frameworks have been adopted by 
Canadian hospitals, broadly all of them have three following structures in common with each other.  
1. Transfusion laboratory staff and medical directors request blood products from the blood 
operator, as needed, and ensure their safe storage and distribution to clinical staff. This group is 
involved in blood products’ compatibility testing to ensure an appropriate match between a blood 
product and a patient. 
2. Transfusion clinical staff, in hospital units where blood is transfused, are responsible for 





3. Transfusion recipients’ physicians order blood products for their patients in need. They are 
responsible for the optimal utilization of blood products and appropriate transfusion practices. It 
is noteworthy that most major hospitals in Canada are equipped with Transfusion Safety Officers 
(TSO) who are responsible for the quality and safety of transfusion within their institutions (Blake 
and Hardy, 2014). 
1.2.4. Patients 
Patients who are the ultimate actor in the Canadian blood supply chain depend on having blood 
components available to them on a daily basis for their specific treatment. Based on the statistics, 
in Canada, 52% of people say they or a family member have needed blood or blood products at 
some point in their lives (Dinerstein, 2018). Our country also needs organ and tissue donors, but 
not enough Canadians have made plans to donate. The need for blood components can be varied 
in various situation, although there is a constant demand for three following blood products: 
• Platelets 
• Blood Plasma 
• Red Blood Cells 
The amount of needed blood is calculated based on the situation that a patient is facing, for 
example: 
• 5 donors to save someone who needs heart surgery 
• 50 donors to help save just 1 person seriously hurt in a car crash 




1.2.5. Supporting Actors 
1. AABB: The American Association of Blood Bank is an international, not-for-profit association 
representing individuals and institutions involved in the fields of transfusion medicine and cellular 
therapies (Blake and Hardy, 2014). As has been mention earlier, Canada is one of the main buyers 
of US blood components (Dinerstein, 2018). This information reveals that although CBS spent a 
major amount of its budget to supply blood components, the action does not have any beneficial 
effects on its performance. 
2. Toyota Canada: Toyota Canada Inc.(TCI) is the exclusive Canadian distributor of Toyota and 
Lexus vehicles.  Toyota and Canadian Blood Services are two organizations with vastly different 
products and services but a similar dedication to quality, efficiency and improving the lives of 
Canadians - an unlikely partnership has turned out to be a perfect match. The first collaboration of 
Toyota and CBS was in 2015 when Toyota helped CBS to figure out all the existing opportunities 
for improving the performances of its production and distribution facilities. The first step of the 
collaboration began with implementing the four fundamental philosophies of the Toyota Canada 
in the CBS organization: 
1. The customer comes first 
2. People are our most valuable resource 
3. Continuous improvement  
4. Shop floor focus- working alongside those closest to the process 
As a result, CBS became able to make the following improvements: 
1. Production and sorting improvements, to gain additional production time of 1 hour per day. 
2. Standardized storage areas to improve workflow, creating additional benefits for 
employees such as less time in -20°C freezers. 
3. 30% reduction in steps taken by employees as a result of reorganized workstations creating 




4. Packing time reduction by 40%. By reorganizing storage areas, making problems more 
visible and standardizing work processes, employees can find the right products quickly 
and accurately (Toyota Website, 2016). 
As of 2017, Toyota Canada has extended its support to CBS with annual donations in order to 
make more people aware of blood and stem cells’ donation, and invite them to participate in these 
donation processes (CBS and Toyota Websites, 2016). In conclusion, it can be realized that the 
collaboration between Toyota Canada and CBS mainly focuses on improving the performance of 
each Canadian Blood Supply Chain’s process.  
1.3. Canadian Blood Supply Chain Processes 
Canadian blood supply chain carries four main processes out in order to safely deliver collected 
blood to the patients: 
1. Shipping and Delivery: After blood components have been collected, CBS sends several 
samples to blood test centers to become sure about blood safety, and delivers the rest of them to 
the Canadian Blood Services production sites. 
2. Storing and Processing: Three various procedures will be followed to store and process the 
donation. In the first procedure, the donations will be put into centrifuges and the whole blood will 
be separated into three layers:  
1. Plasma 
2. Buffy Coat 
3. Red Blood Cells(RBCs) 
In the second procedure, the donations will be further processed based on the patients’ needs. In 
the last procedure, donations will be kept in the interim storage before being labelled. It should be 
noted that considering Toyota Canada’s recommendation to use sorting benches results in an 88% 




5. Labelling and Storage: If the test results show that the donations are suitable, they will be 
labelled and put into finished-product storage. All the components will be kept in storage sites 
until they are needed for a hospital order. Figure 1.6 shows the storage time and method that is 
required for each blood component. Rearranging storage areas and freezers was another Toyota 
Canada’s recommendation that has been implemented in the storage sites and caused improvement 
in the workflow and employees’ performance. 
Figure 1.6 - Storage time and method for each blood component (Ballem, 2018) 
6. Distribution: This is the last step in the Canadian Blood Supply Chain Process. As has been 
mentioned before blood components will be distributed based on the orders that CBS receives 
from hospitals. Hospitals’ orders can be divided into the two main categories: 
1. Routine Hospital orders 
2. STAT(immediately) orders 
Routine Hospital orders are regularly delivered to the hospitals to keep a constant supply of blood 
to the hospitals. STAT orders are only transferred during emergency situations when hospitals 
need a certain blood component quickly.  
1.4. Blood Components 
Blood is a living tissue that carries nutrients to and wastes away from all parts of the body. Blood 




can be transfused to the patients as pint(s) of either whole blood or a specific blood component. 
Figure 1.7 shows the percentage breakdown of blood by component in one single unit of whole 
blood.  
 
Figure 1.7- Blood Components Percentage in a Unit of Whole Blood (Ballem, 2018) 
The blood components that are used in a blood transfusion process are Red Blood Cells(RBCs), 
Platelets, and Plasma. Each of these blood components should have its own supply chain network 
according its own specific characteristic and storing condition.  
1.4.1. Whole Blood 
Whole Blood is the simplest, most common type of blood donation. It’s also the most flexible 
because it can be transfused in its original form, or processed further to be separated into its specific 
components of red cells, plasma and platelets. Whole Blood donations require minimal processing 
before it is ready to be transfused into a patient. (Ballem, 2018) 
1.4.2. Red Blood Cells (RBCs) 
Red blood cells account for 45% of whole blood consists. RBCs are prepared from whole blood 




shelf life and they should be stored in a refrigerated condition. The common applications RBCs 
include trauma, surgery and blood disorders.  “AB0” blood types are established on RBC surfaces, 
and according to blood types’ specific demand and supply amounts, each of them has its own 
planning in the RBCs supply chain (Zahiri et al, 2018). 
1.4.3. Platelets 
Platelets (Figure 1.8) constitute less than 1% of whole blood and are considered as the rarest blood 
component. Platelets 5 days’ usability period have the shortest shelf life among all blood 
components. Therefore, due to the limited available time, all the required actions to deliver these 
units to hospitals and transfuse them to patients should be the fastest. Platelets can be extracted by 
using a centrifuge process called platelet-rich plasma therapy to separate plasma and platelets from 
donated whole blood. Platelets from several different donors are then combined to make one 
transfusable unit. 
Alternately, platelets can be obtained using an apheresis machine which draws blood from the 
donor’s arm, separates the blood into its components, retains some of the platelets, and returns the 
remainder of the blood to the donor. If donors donate platelets units by using an apheresis medical 
technology, they can contribute about four to six times as many platelets as a unit of platelets 
obtained from a whole blood donation (Ballem, 2018). The obtained platelets should be stored in 
a room temperature condition. The common applications of platelets include cancer treatment, 
organ transplant and surgery.  
1.4.4. Plasma 
Plasma constitutes 55% of whole blood. Plasma has the longest shelf life between blood 




several important functions in human body, despite being about 92% water. (Plasma also contains 
7% vital proteins such as albumin, gamma globulin and anti-hemophilic factor, and 1% mineral 
salts, sugars, fats, hormones and vitamins). It helps maintain a satisfactory blood pressure and 
volume, and supplies critical proteins for preventing blood clotting and immunity. It also carries 
electrolytes such as sodium and potassium to the muscles and helps to maintain a proper pH (acid-
base) balance in the body, which is critical to cell function (Ballem, 2018). In a transfusion process, 
plasma is used for burn patients, shock and bleeding disorders applications. 
1.4.5. Conclusion 
 In conclusion, Table 1.2 shows a summary of all related information to the blood types which 
have been described. 
Table 1.2- Summary of Blood Types Information (Ballem, 2018) 
(See Figure 1.6) 
Blood Types Color Shelf Life Storage Conditions Key Users 
Whole Blood Red 21/35 days Refrigerated Trauma, Surgery 
Red Blood Cells 
(RBCs) 
Red Up to 42 days Refrigerated 
Trauma, Surgery, 
Anemia, Any blood 
loss, Blood disorders 
Platelets Colorless 5 days 
Room temperature 
with constant 
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1.5. Problem Statement 
According to the WHO’s recent statistics, 107 out of 180 countries around the world do not have a sufficient 
inventory of blood units to meet the demands of their population (McDonnell, 2019). Currently, CBS adopts 
two main approaches to deal with the blood shortage issue in Canada: 
1. Invite new blood donors: For two years in the row (2018-19), CBS has been repeatedly calling for 
100,000 new blood donors to sign up to meet the anticipated demand for blood.   
2. Buy blood components from US: Buying blood from US is the second approach used by CBS 
organization to face the shortage issue. The amount of blood components in each order 
determines by using the forecasting approach and considering the existing shortage. In 
2016, Canada paid the US 512 million dollars to provide blood components for unsatisfied demands 
(Dinerstein, 2018). This shows that Canada is heavily dependent on the US to satisfy the 
existing demands and avoid shortage. 
At the same time, CBS has reported that more than 10% of platelets has been discarded in April 2018 (See 
Figure 1.5). Since both issues of shortage and outdated units are co-existing in the CBS organization at the 
same time, one can imply that the current blood management tactical planning at CBS are not effective to 
organize supply chain that can manage both shortage and outdated units’ issues simultaneously. However, 
since blood supplying depends heavily on availability of donors, CBS should continue exploring other 
approaches such as, for example, lateral transshipment and emergency ordering methods to mitigate this 
dependency. Applying these approaches in the supply chain to redesign the process may provide a suitable 
condition for CBS to use the existing inventory in a way that the amounts of discarded units’ and shortage 




effectively monitor the inventory level of all the internal actors and make a decision that help all the actors 
to improve both their performance and efficiency.  This research aims to explore solution for a blood 
network supply chain redesign  process in which CBS can be in the green phase (See Table 1.1), and satisfy 
at least 80% of the blood components’ shortage.  
1.6. Approach 
This chapter reveals the importance of blood supply chain performance due to its life-saving 
product. With regarding the blood’s nature and Canadian blood supply chain configuration, this 
study proposes to develop and explore a mathematical model that can be implemented in a local 
level of Canadian blood supply chain. It will help to understand (by studying various scenarios) 
how to achieve both inventory management and reduce all the costs..  
Perishable nature of blood products and uncertainty of supply and demand expose concurrently 
Canadian blood supply chain to both shortage and expiration issues at the same time, therefore, 
the proposed model must be able to reduce both the shortage level and expired amount of the 
system together. By reviewing the available research, the currently existing gaps in the blood 
supply chain field and the direction of this research are to be determined. This study considers 
three main categories of actors in a blood supply chain:  
1. Mobile Collection Centers 
2. Blood Centers 
3. Hospitals 
In addition, available blood transportation modes can be expanded to offer the proposed centers 
more flexibility and help optimize the blood units’ flow between every two centers. 
Available information shows that the current actions such as, for example buying blood from US 
and inviting people to donate blood which CBS is under taking to deal with blood shortage and 




purposes and quantifies two additional approaches as possible enhancements to the blood supply 
chain performance: 
1. Reactive Lateral Transshipment 
2. Emergency Ordering 
The reactive lateral transshipment approach is an option that allows hospitals to order blood units 
from other hospitals and clinical centers if the former faces shortage. 
Emergency ordering approach also allows hospitals to order blood units from blood centers 
directly if they face shortages. The mobile collection centers in this research are temporary centers 
that can just collect the blood units and transfer them to the blood centers. Blood centers are the 
next stage of the proposed supply chain in which the blood units will be collected, tested and 
stored. Hospitals are the last stage of the suggested model, hospitals can order blood directly from 
blood centers in a normal situation, or ordering blood from blood centers or other hospitals during 
an emergency situation.  
The fact that blood components are perishable and errors that can happen in the test results and by 
staff have been considered in the model as well. A limited capacity for all the centers and available 
transportation modes have been considered in order to make the proposed model closer to a real-
world situation. Furthermore, to reduce outdated units, a FIFO (First in, first out) system has been 
applied in both hospitals and blood centers. Optimization modelling and applying a case study 
approaches have been used in this research to show how the proposed model would behave in the 
real world. The Greater Toronto Area(GTA) has been considered as the case study of this research, 





1.7. Thesis Overview 
The remainder of this study is organized as follows. In Chapter 2, the blood supply chain network’s 
relevant research works, their approaches and achievements are described. In Chapter 3, necessary 
information to redesign a blood supply chain network has been introduced and a mathematical 
model has been developed by considering the assumptions. The research’s case study has been 
introduced in Chapter 4, and all the required data to solve the proposed model has been explained. 
Chapter 5 shows the numerical results obtained by solving the model, and also demonstrates the 
model’s sensitivity towards parameters’ changes. In Chapter 6, a novel solution has been suggested 
to solve the infeasibility problem caused by unexpected changes in the parameters. Conclusions 
and recommendation for future research works are presented in Chapter 7. 
1.8. Contributions 
The following contributions have been implemented in this study. 
1.8.1. Reactive Lateral Transshipment Approach 
Reactive Lateral Transshipment approach provides an opportunity for hospitals to request blood 
components from other hospitals in case of need. Applying this approach in the proposed model 
is a novel contribution. If implemented, it would not only reduce hospitals’ shortage level and save 
more lives, but also does it have positive effects on the reduction of outdated blood units’ amount.  
1.8.2. Emergency Ordering Approach 
Emergency Ordering approach is another way that can be used by hospitals, if they face with any 
shortage. Considering this option in the suggested model is a new contribution. If applied, it 
provides an additional opportunity for hospitals in case of they cannot satisfy their shortage level 




1.8.3. Transportation Modes 
The proposed multimodal transportation framework is a novel contribution to this field. If 
implemented, both blood centers and hospitals have the opportunity to use various modes to deliver 







2.1. Chapter Overview 
This chapters shows some the most discussed issues over the past few years regarding healthcare 
and specifically blood supply chain. Figure 2.1 is a map stream that demonstrate the process of 
literature review in this research. 
 




2.2. Blood Supply Chain Network 
The healthcare supply chain is recognized as one of the common area between both engineering 
and healthcare sciences fields (Aghazadeh et al, 2017). World changes constantly these days, and 
healthcare industry has to keep itself updated to be able to have both effective and efficient 
management. To achieve this goal, all the key elements of the healthcare system should first be 
identified, and then be optimized by considering all the new circumstances. The blood supply chain 
is considered as one of the critical elements of the healthcare system. Hence, any improvement in 
blood management can have a significant impact on the performance of the healthcare system. 
(Zahiri et al, 2015). Considering a multi-period planning horizon, perishability of blood, 
uncertainty in demands and supplies, blood substitution transfusion, and blood delivery system 
framework are the elements that affect blood supply chain performance, and also offer 
opportunities for improvement (Zahiri et al, 2015; Kaveh and Ghobadi, 2017).  
Nowadays, blood availability is one of the major problems that developed countries are facing, 
and blood supply chains are dealing with various challenges such as, for example an increase in 
operating costs, a rise in competition among blood centers, donors’ motivation, seasonal shortages 
and blood components’ perishability (Dutta, 2019). Organized inventory management that is 
achieved by understanding the complex interrelations of supply and demand and other factors that 
affect them, would be fruitful to discover the blood supply chain configuration that should be used 
in order to overcome detrimental effect of this complexity (Chapman et al, 2004). Choosing 
between centralized or decentralized structure is one of the ongoing debates among healthcare 
preferences. Each of these structures has its own advantages and disadvantages. For instance, it 
appears that hospitals see cost advantage in decentralized blood centers, while the centralized 




2006). Information flow in the supply chain is a key element that has a significant impact on both 
the supply chain’s effectiveness and donors’ satisfaction. An integrated supply chain in which 
information is shared across the entire system can be viewed as a successful framework leading to 
improve of the supply chain’s performance (Grant, 2010). As an example, Enterprise Resource 
Planning (ERP) is known as a well-known tool to manage the information flow in manufacturing. 
The application of ERP in the blood supply chain field promises benefits from increased efficiency 
to improved quality, productivity, and profitability. Automatic Replenishment Programs (ARPs) 
is another tool that uses information sharing between supply chain members to discover how 
inventory should be managed. The application of these programs can reduce costs and lead times, 
and improve service level and productivity (Angulo et al, 2004). In conclusion, it can be realized 
that selection between centralized and decentralized structure or an in-between structure is highly 
dependent on the goals which blood supply chain are seeking. At first, it should be identified 
whether the main purpose is to minimize the total costs or to maximize the actors’ satisfaction 
(Gupta et al, 2004). 
2.3. Simulation Approach to Forecast Trends 
Blood operation centers are responsible for a wide range of activities such as, for example blood 
collection from donors, blood processing and blood components distribution to hospitals and 
clinical centers. Usually, blood operation centers are focused on satisfying hospitals’ demand in 
their own geographic area, but occasionally also provide blood for hospitals located sometimes 
even hundreds of miles away (Nagurney et al, 2012). Therefore, it can be realized that such centers 




Although forecasting methods are mainly recognized as tools that are useful in manufacturing and 
commercial activities, the ability to forecast the amount of blood components’ demands can be 
considered as an effective step which can both reduce the shortage stress, and increase efficiency 
(Caulfield, 2013). In today’s world, technology provides a wide range of methods for anticipating 
products’ demands, computer simulation approach is one of those methods that help managers 
prepare for a situation in which healthcare decisions can make an effective decisions regarding all 
of the blood supply chain’s policies (Rytilä & Spens, 2006). The simulation results reveal all the 
essential information about the existing concerns, potential impacts and value-added activities that 
exist in a supply chain system. Consequently, by studying all these results, the decision-makers 
will decide about the effectiveness of the proposed model in the real-world situation (AbuKhousa 
et al, 2014). (Kopach et al, 2003) developed prototype simulation models to predict the likelihood 
and assess the subsequent medical consequences of blood product shortages. To make the model 
closer to reality, several factors such as uncertain supply and demand, suppliers’ and consumers’ 
policies and blood matching rules have been considered. The study was run in three different 
simulation environments, representing urban, semi-urban and rural areas. 
A computational environment created by (Filho et al, 2013) in which using the Box-Jenkins (BJ) 
procedure has led to a forecasting method that can be used by blood centers during the blood 
components’ demands estimation process instead of adopting traditional ordering policy methods. 
Economic theory implies that the national blood supply can be increased either by increasing the 
level of resources used in the collection and production of blood components or by utilizing 
existing resources more efficiently (Pitocco & Sexton, 2005). Due to the limited budgets, most of 




Hence, it is essential to realize how major problems and their root causes in an existing blood 
supply chain can be identified. 
(Lowalekar and Ravi, 2017) proposed a TOC thinking process for the blood supply chain, in India. 
The supply chain faced various problems such as high shortage and outdated units’ rates, large 
inventory levels, poor and erratic blood collection, high error rate and etc. Although the mentioned 
issues seemed to be independent, applying the proposed TOC approach in a simulation model 
revealed that they were all inter-related and originated from a single root-cause. 
2.4. Blood as a Perishable Product 
In contrast to many traditional supply chains, perishability of blood components, forces focus in 
blood supply chain on both responsiveness and efficiency factors simultaneously. This is because 
fresh products like blood have their own Marginal Value Time (MVT) which shows the change in 
the value of product per unit time at a given point along the supply chain. Any change in MVT of 
the blood products drives up the costs of the blood supply chain (Blackburn and Scudder, 2009), 
hence, managing blood inventories is a trade-off of shortages and lost sales against the amount of 
outdated units (Stanger et al, 2012). 
(Katsaliaki et al, 2014) introduced a game-based empirical approach to decision making which has 
the two main characteristics: 
1. Perishability 
2. Limited product collection/production. 
The blood supply chain game that has been proposed in the paper gave the audience the ability to 
study the supply chain from different points of view. During the game, the participants have 
acquired knowledge about the push/pull process in order to understand how they should set the 




control practices, transportation assignment techniques, costs management and bullwhip effect 
have been introduced and studied during the game either in order to make the game more realistic.  
 The bullwhip effect used to forecast supply chain inefficiencies is known to cause excess 
inventory (Lee et al. 1997) which in turn can increase the outdated units’ rate of perishable 
products. (Rutherford et al, 2016) realized that inefficient management of the relationship that 
exists between blood operation centers and hospital blood banks was the main problem responsible 
for the bullwhip effect in a blood supply chain system. 
Knowing the fact that humans are the only resource for supplying blood components, and there is 
no other artificial substance that can be considered a good replacement for this scarce product, 
emphasizes the importance of having a precise planning in every stage of a blood supply chain 
especially hospitals and clinical centers who are responsible for blood transfusion. Najafi et al 
(2017) presented a mathematical model to manage blood ordering and issuing policies in hospitals. 
The ability to transshipment blood components between the nodes located within the same SC 
stage, and recognizing whether the patient can receive blood of any age or only fresh blood can be 
transfused made the model more realistic.  
2.5. Blood Supply Chain Behavior in Uncommon Situations 
Some supply chains maintain the same response policy in every situation, while others need to 
have various planning depending on the model scenario that is taking place. Blood supply chain 
belongs to the second group because blood components can be considered as one of the vital 
supplies in which their demands increase dramatically during an emergency situation. Moreover, 
a blood supply chain is an inseparable part of the healthcare system. Therefore, any disruption in 




1990, natural disasters have claimed more than 3,000,000 people around the world, affecting 
8,000,000 lives. (Schultz et al, 1996). After a series of earthquakes in 1999, Turkish Red Crescent 
(TRC) has engaged in restructuring for all of its activities, including the blood services, (Sahin et 
al, 2005) proposed a location-allocation mathematical model to increase the countrywide service 
level of the blood centers. The models’ structure contains two main levels: 
1. Upper-level: includes all the regional blood centers.  
2. Lower-level: includes blood stations, mobile units and blood centers. 
As a result, finding the proposed model helped TRC to increase the effectiveness of its current 
sites and find the optimal locations for establishing the new sites. 
Similarly, after the Wenchuan earthquake in 2008 in China, the government realized that the lack 
of integrated scheduling for the transportation supply chain led to a shortage in some areas while 
other areas discard outdated blood units. To improve the uneven distribution, (Sha and Huang, 
2012) presented a mathematical model in which all the decisions related to scheduling, location 
and allocation of blood components have been taken. The proposed model provided a framework 
in which cross-matching requirements over different regions have been satisfied. By reviewing 
these research works, it becomes clear that healthcare facilities’ location problem has a significant 
impact on both minimizing the cost and maximizing the performance (Ghane & Tavakkoli-
Moghaddam, 2018). 
Research efforts in the area of an integrated blood supply chain network when disaster strikes have 
been increased dramatically over the past few years. This is because, due to climate change and all 
other related issues, frequency of natural disaster has increased more than ever before. It is 
anticipated that an integrated supply chain can offer ability to reduce the death rate and injuries. 
(Fahimnia et al, 2017) suggested a framework for the blood supply chain which consisted of blood 




this 4-stages blood supply chain was to simultaneously improve both the efficiency (cost-
minimizing) and effectiveness (delivery time minimizing).  
To improve the accuracy of planning for blood distribution in an emergency situation, (Habibi et 
al, 2018) proposed a mathematical model that has two main objectives: to minimize both costs and 
blood shortages. The model considered several factors such as multi-period time horizon, robust 
uncertainty, and establishing permanent facilities to be more realistic. In the end, it has been 
realized that expanding the budget to a reasonable level will be helpful to be completely prepared 
for supplying the blood components’ needs during an emergency situation like when a disaster 
strikes.  
(Samani et al, 2017) suggested a blood supply chain network design that considered 
simultaneously efficiency, responsiveness and effectiveness, which are three major issues in any 
blood supply chain, simultaneously. Since some patients can only receive fresh blood, and any 
inadequacy in blood components can cause an increase in the death rate, the model aimed to 
minimize the time span between blood production in operation centers and consumption in demand 
zones in order to keep the blood components fresh besides the two previous objective functions.  
The magnitude of disasters and their destruction level, various transportation modes, blood 
substitution, and reliability are other aspects that have been considered in the latest research work 
to make them closer to the real-world situation (Khalilpourazari & Arshadi, 2017; Fazli-Khalaf et 
al, 2017; Salehi et al, 2017).  
Although the importance of supplying commodities such as water, food and shelter during the 
post-disaster phase is undeniable, the delivery of medicine such as blood is incomparable 
importance because blood components’ transfusion has a direct impact on humans’ lives, and even 




2019) presented a mathematical model in which time and cost of delivering products have been 
minimized under various disaster scenarios. Moreover, disruption, which is an inseparable part of 
any disasters’ scenario, has been implemented in the model to understand how blood transportation 
can be carried out when disruption affected the facilities or routes. 
Responding to a disaster consists of three different phases:  
1. Pre-disaster phase 
2. Disaster phase 
3. Post-disaster phase 
(Jabbarzadeh et al, 2014) suggested a mathematical model that focused on improving the blood 
supply chain’s performance during the post-disaster periods. Concerns regarding how all the 
operations should be managed to achieve the best responsiveness manner are at the highest level 
during the post-disaster phase. Thus, establishing a framework in which all the costs are 
minimized, and the blood inventory levels at each period have already been determined, can 
improve the performance level dramatically. 
It is worthwhile to mention that during each phases of a disaster, there are various factors that 
affect the supply chain’s performance. Hence, creating an integrated supply chain network in 
which all the phases have been considered will be a great help to increase the preparedness. 
(Eskandari et al, 2018) proposed a mathematical model that its main goal was to create a 
framework where the blood supply chain’s efficiency can be increased during the disaster and 
post-disaster phases. The framework has been studied from three different perspectives: 
1. Mitigating the environmental impacts that are caused by blood facilities’ construction, and 
blood components’ transportation. 
2. Maximizing the blood supply chain’s social impacts by providing various job opportunities 




3. Minimizing the various costs that are associated with blood collection, preparation, 
transportation and transfusion. 
Uncertainty has been applied in the model as well due to the nature of both blood and disaster.  
The Military Blood Program called Armed Service Blood Program (ASBP) has a reach worldwide 
program. ASBP consists of several organizations, and all of them are committed to function 
together to assure that blood supply chain management can be run successfully during a man-made 
disaster, such as war. To have a better performance in all involved organizations, (Delen et al, 
2011) proposed a hierarchical management structure by using data mining and GIS tools to be 
implemented in the ASBP’s organizations. 
Besides the disasters and emergency instances, there are some other times, as, for example 
religious events or statutory holidays (eg. Lunar New Year in China) in which the rate of blood 
donation decreases dramatically. In anticipations of such slowdown volumes of blood 
components’ demands should be forecasted based on the previous data in order to prevent any 
shortages. (Haijema et al, 2009) suggested a stochastic dynamic programming to study ordering 
policies that should be set in a platelet supply chain to manage rate of both expiry and shortage. 
Furthermore, they conducted simulation studies to understand the effect of events such as, for 
example Easter and Christmas which break the production and lead to shortages. As a result, it has 
been concluded that during the production break events the management of the blood supply chain 
would be completely different.  
2.6. Blood Transportation System 
Perishability of blood products and uncertainty in both demands and supplies, make blood 
transportation planning as one of the major issues which managers deal with. (Hemmelmayr et al, 




address the uncertain nature of blood supplies and demands, a variety of emergency delivery 
options were also implemented in the model. 
In most recent research, transportation planning of the blood supply chain is studied from two main 
perspectives: 
1. Reliability: Blood supply chains have to deliver blood components in a way that minimize 
blood’s discard rate.  
2. Efficiency: The total cost of the network should be minimized (Zahiri et al, 2018). 
(Zahiri et al, 2018) proposed a mathematical model that focused on vehicle routing planning to 
improve both the reliability and efficiency of a blood supply chain. A stochastic programming 
approach has been implemented in order to cope with all the existing uncertainties. In addition, a 
combined scenario tree has been adopted to integrate collection, production, screening and 
distribution nodes in order to be able to manage all the necessary action which are helpful to 
achieve these goals.  
From another point of view, manage blood delivery according to demand centers' needs and 
optimized internal management of the blood supply system besides cost efficiency and reliability 
are other factors that help to create efficient planning for the blood supply chain network. 
(Ghandforoush and Sen, 2010) presented an approach that contains Decision Support System 
(DSS) and non-convex integer optimization methods. In the first step, the DSS method has been 
used to support the supply chain of the blood production process. Optimization of the mobile 
scheduling system based on a non-convex integer programming model, led to a conclusion that 
removing utilized mobile centers is the optimal option to reduce maintenance expenses and 
improve transportation and staff time.  
In some cases, the mobile blood collection centers have been designed to operate only the functions 




distribution, have to be done by other blood operation centers. Thus, mobile blood centers should 
deliver their collected blood to the blood centers on a regular basis. (Sahinyazan et al, 2015) created 
a mobile blood collection system in which collected blood should be transferred to the blood 
operator center at the end of each day in order to avoid the risk of blood spoilage. Increasing the 
amount of daily blood collection at a reasonable cost is the main goal of implementing mobile 
blood centers. However, if the mobile centers have to transfer the collected blood by themselves, 
some parts of their operational time would be wasted, and all related transportation costs would 
increase dramatically. Therefore, the model introduced a new vehicle called shuttle which has a 
job is to visit the mobile blood centers at the end of each day to deliver the collected blood to the 
blood operators. As a result, the optimal routing solution has been suggested for both mobile 
centers and shuttles to reduce all the related costs.  
Lateral transshipment is one of the common tools in supply chain management deployed to deal 
with shortage and waste. Lateral transshipment occurs when a product must be transferred between 
the nodes in the same stage. There are two types of lateral transshipment: 
1. Reactive Transshipment 
2. Proactive transshipment. 
Implementing lateral transshipment in a supply chain can be helpful to prevent any shortages and 
mitigate any waste. Also, it helps to reduce costs. Like any other supply chain, the blood supply 
chain is dealing with shortage and outdated units’ issues, too. Hence, both transshipment methods 
have been applied in various blood supply chain networks in order to obtain desirable results in 
both inventory management and cost reduction fields. (Larimi et al, 2019) presented a 
mathematical model in which both total costs and maximum unsatisfied demand have been 




of blood contains less than 1% platelets shows the importance of having a separate organized 
supply chain for delivering this component. To overcome these obstacles and uncertainty issues, 
the model assumed lateral transshipment as an opportunity that provided a situation in which 
platelets can be transferred between all the clinical centers and hospitals. Lateral transshipment in 
this study was of a reactive kind, meaning that platelets were transferred between hospitals and 
clinical centers only when any platelets’ shortage occured.  The results showed that not only the 
proposed model reach its own goals, but it also improves demand satisfaction. 
On the other hand, (Dehghani et al, 2019) believed that proactive transshipment would be more 
useful reaching reduction costs, shortage and outdated units in the best possible way. By applying 
the proactive transshipment in the hospitals’ supply chain networks, the “order-up-to” rule (Dijk 
et al, 2009) in which the orders would take place at fixed points of time before observing the 
demand has been applied in to the model. Moreover, by using the Quasi-Monte Carlo sampling 
approach several scenarios have been generated to deal with the uncertain nature of blood 
components’ demands. 
2.7. Blood Components’ Specific Supply Chain  
As has been mentioned in Chapter 1, each blood component has its own specifications which may 
lead to creating a more customized supply chain for that particular blood component. (Ensafian et 
al, 2017) proposed a mathematical model in which the age of the platelets and ABO-Rh priority 
matching have been considered. The tactical and operational decisions in this model were obtained 
by considering a multi-period time horizon. To reduce uncertainty, the number of donors was 
forecasted by using a discrete Markov chain process. The platelet’s demand was the only factor in 




suggested model were to reduce all related costs and manage the existing risk in a way that both 
the expected value and variance of the costs would be reduced.  
The short shelf life of platelets (compared to other blood products) managing their inventory is 
one of the main challenges in the blood supplying system. (Fontaine et al, 2009) Establishing an 
inventory bank can have positive effects on the four main factors that are in a direct connection 
with the blood supply chain’s effectiveness: 
1. Blood shortage 
2. Outdating 
3. Inventory level 
4. Reward gained 
(Abdulwahab and Wahab, 2014) suggested a mathematical model to control the inventory level of 
blood platelets. The proposed blood platelet bank dealt with eight blood types, stochastic demand 
and supply, and deterministic lead time. By applying the newsvendor model and dynamic 
programming it was verified that by minimizing the first two mentioned factors, the inventory 
level was optimized, therefore, the blood platelet bank reward was maximized.  
While some of the patients have to receive fresh blood components, while others can be cured by 
old blood components. Blood substitution can be considered as an option in case of any emergency 
need, especially for type two patients.  (Civelek et al, 2015) proposed a blood platelet inventory 
management model by following a Markov Decision Process (MDP) to show that shortage, 
expiration and holding costs are not the only factors that can affect the inventory planning. 
Introducing a substitution option and its related cost provided an opportunity for the model to 
satisfy a demand for a certain-aged item by using a different-aged item if the substitution matches 




The fact that the number of donors has a significant effect on the blood supply chain performance 
is undeniable. In today’s world, the limited number of donors, and the increasing rate of blood 
demands are the problems that make the blood supply chain planning even more complex. 
(Rajendran and Ravindran, 2019) proposed a stochastic mathematical model that considered the 
two aforementioned problems for a platelet supply chain. The outdated units’ and shortage 
problems not only increase the costs dramatically, but also they delay all the operational functions 
like surgeries or organ transplants. Therefore, having a precise ordering policy can improve the 
performance of both blood operators and hospitals.  
Based on the latest report (Chargé, 2019) Canadian blood supply chain is categorized as a 
comprehensive supply chain that includes all the organizations involved in all the upstream and 
downstream flows of products, services, finances, and information from the ultimate supplier to 
the ultimate customer (Mentzer et al, 2001). Controlling these organizations requires an integrated 
plan in which all the necessary policies for operating the supply chain have been defined. (Blake 
et al, 2003) proposed three phases simulation model for the platelet supply chain that has been 
applied in the Nova Scotia region. The first phase of the model gathered all the necessary 
information. In the second phase, by applying a dynamic programming model on the obtained 
information, locally optimal ordering policies for both producer (CBS) and consumers (hospitals, 
and clinical centers) have been identified. The last phase runs the model in a simulation 
environment in order to realize its effectiveness. 
RBC is another blood component that has its own specific supply chain.  It has been discovered 
that during storage phase, RBCs undergo biochemical changes, which are referred to as “storage 
lesions” (Fontaine et al, 2010), hence, the inventory stock rate and holding time are the two topics 




of scheduled shipments from the blood supplier, the average age and the volume of the shipped 
stocks are the factors that affect holding time and inventory rate (Pereira, 2005). (Katsaliaki, 2008) 
provided a risk-free environment by using a discrete event simulation model in order to both reduce 
the costs and increase safety. The simulation study has shown that taking some necessary actions 
like holding stock of rare blood groups of RBC, having a second routine delivery per weekday, 
adhering an age-based issuing of order, etc., would help blood banks to reach to the optimal level 
the outdated, group substitutions, shortages and deliveries. 
Although various methods such as, for example encouraging people to donate blood by advertising 
and constructing permanent or mobile blood collection centers have been applied to improve 
balance between blood supply and demand, blood substitution option can be recognized as the 
most cost-effective one, especially for RBC and Plasma products that in the clinical practice, have 
longer shelf lives than the other blood components (Zahiri & Pishvaee, 2017). Considering blood 
group compatibility not only reduces the outdated units’ rate, but also does decrease the cost. 
(Duan and Liao, 2014) suggested a simulation framework for the RBCs supply chain, where the 
main goal was to minimize the expected system outdated rate under a predetermined maximally 
allowable shortage level. Blood substitution is one of the most useful methods in order to manage 
both shortage and outdated units’ amounts. Thus, three different scenarios have been considered 
in the simulation framework. The first scenario did not allow any blood substitution either at the 
hospital or the blood center. The second scenario considered blood substitution only at the hospital 
stage, while the third scenario let the blood components be replaced with their compatible at both 
hospital and blood center stages. In addition, all three scenarios have been tested with three levels 
of maximal shelf lives: 21, 14 and 7 days. In conclusion, it has been figured out that the third 




if financial problems did not let to have blood substitution in both two stages, the second scenario 
should be considered.  
Both shortage and outdated units’ issues can threaten not only the supply chain, but also the whole 
environment. That is why, shortage can increase the rate of death rates, while outdated units’ issue 
can put the environment’s sustainability in danger. (Nagurney & Masoumi, 2012) Moreover, 
shortage and outdated units’ amounts optimization are two conflicting goals because a large 
amount of stored products improves demands’ satisfaction while it will increase the storage time 
for the blood components as well (Baesler et al, 2014). Thus, a flexible blood supply chain network 
can be useful in this kind of situation that some of the hospitals and clinical centers are facing 
shortage while others are dealing with a large amount of outdated units. Flexibility in a supply 
chain can be obtained from various ways. (Jafarkhan and Yaghoubi, 2018) proposed a 
mathematical model for an RBC supply chain network. By adding the possibility of lateral 
transshipment and using compatible blood types (substitution) in case of any shortages, the model 
became flexible. As a result, it has been realized that transshipment can be useful to reduce the 
shortage and the total costs, and substitution can be applied when the demand rate is high. In 
addition, (Ekici et al, 2018) realized that 1. Increasing donors; utilization, and 2. Tailoring the 
donations based on the demand can be considered as fruitful tools to deal with outdated units’ and 
repeated blood donation problems. 
Besides, lateral transshipment and blood substitution options, there are several other options that 
can affect the supply chain’s flexibility. (Dillon et al, 2017) presented a mathematical model that 
aimed to minimize all the operational costs. Different planning horizons, various lead times and 
shorter or longer shelf lives have been considered in the model in order to expand the solution area 




high rate of uncertainty that existed in both blood components’ demands and supplies, a stochastic 
approach by considering various scenarios has been implemented in the model in order to reach to 
ordering policies that can be applied in the real world. 
As it has been discussed before, to overcome the shortage problem, establishing mobile blood 
collection facilities is a way that can provide a convenient situation in order to encourage more 
people to donate their blood. (Hamdan and Diabat, 2019) suggested a two-stage mathematical 
model for the RBC supply chain that the first stage of the model focused on finding the optimal 
locations for mobile blood collection centers, and the second stage determined an integrated 
framework for both inventory and distribution decisions. Minimizing the number of outdated units, 
system costs, and blood delivery time were the fundamental factors that have been considered in 
these strategic and tactical decisions. 
From another point of view, it can be considered that both RBCs and platelets have short lifetimes. 
Therefore, an integrated blood supply chain that can satisfy both components’ requirements would 
be useful in the situation that blood operators have time and cost limitations which prevent them 
from having a separate supply chain for each of these components. (Gunpinar and Centeno, 2015) 
proposed a set of mathematical models in which various factors such as two patients’ types, 
demands’ uncertainty rate and crossmatch-to-transfusion ratio have been considered in order to 
provide a situation in which storage, outdated units’ and production costs would be minimized. 





2.8. Hospitals Management System 
Hospitals are recognized as the largest customer of the blood components around the world, and it 
is their responsibility to ensure that donated blood is used efficiently and effectively (Perera et al, 
2009). Therefore, it can be realized that managing hospital inventory in order to deal with 
nonstationary demand is a major issue for hospitals all around the world (Hemmelmayr et al, 
2009). In 2004 the Chief Medical Officer’s National Blood Transfusion Committee for England 
and North Wales (NBTC) issued guidance on how hospitals should prepare contingency plans to 
deal with a shortage of red cells for transfusion. (Britain, 2004; Galloway et al, 2008). After 
declaring the guidance, some research works have been conducted to realize whether the guidance 
was helpful for hospitals and clinical centers or not. (Stanger et al, 2012) analyzed the related data 
of 277 hospitals in England and North Wales to realize what methods have been used for reducing 
RBCs outdated amount. Interviewing with blood inventory managers in the top-performing 
hospitals revealed 6 key themes that together drive good performance in blood stocks inventory 
management. These themes are human resources and training, stock levels and order patterns, 
transparency of inventories, simple inventory procedures, focus on freshness, and internal 
collaboration within the hospital. All these factors revealed the importance of having high quality, 
trained and experienced staff. Hence, it would be realized that the proposed models should consider 
hospitals’ staff as a factor that can make the models closer to reality. It also has been realized that 
for having successful inventory management in other stages of a blood supply chain, techniques 
from commercial supply chain management can be useful methods (Yates et al, 2017). 
Reserving frozen blood in the hospitals and clinical centers’ storage is another solution to deal 
with short-term shortages that can be caused by seasonal shortages, weather conditions, and 




case of any shortages in RBCs, and it has been concluded that although the application of frozen 
blood had its own costs, its benefits far outweighed its cons. 
In some cases, it has been realized that the application of some specific methods in the healthcare 
field cannot produce desirable results. For instance, (Stanger, 2013) conducted a study in which 
some of Germany’s hospitals were involved in order to realize that whether the application of 
vendor managed inventory (VMI) in these hospitals was useful or not. Although VMI provided a 
situation in which suppliers controlled every detail related to blood components’ flow in the supply 
chain, given to the obtained results, it has been discovered that hospitals were not satisfied with 
existing situation because they were completely dependent on the supplier, and they could not 
manage any of their blood products’ inventory by themselves. Thus, this real case study reveals 
that however some inventory policies are really successful in the commercial fields, they can be 
implemented in non-commercial sections like the healthcare industry. 
2.9. Blood as a Medicine 
The main purpose of blood transfusion is to cure the various type of blood-related diseases such 
as Trauma, Anemia, Cancer Treatments, Organ Transplants etc., and blood is considered as a 
medicine in these transfusions. Hence, blood supply chain management can be recognized as a 
subset of the pharmaceutical supply chain network.  Nowadays, many countries heavily regulate 
their pharmaceutical supply chains because of the new challenges that are happening every day 
(Papageorgiou, 2001; Yu et al, 2010). Therefore, as the first step, it is essential to realize the main 
challenges that global health pharmaceutical supply chains are faced with. (Privett and Gonsalvez, 
2014) conducted a series of interviews and surveys in order to identify and prioritize these issues. 




supply chain in the world is dealing with. Respectively, the challenges are 1. Lack of coordination, 
2. Inventory management, 3. Absent demand information, 4. Human resource dependency, 5. 
Order management, 6. Shortage avoidance, 7. Expiration, 8. Warehouse management, 9. 
Temperature control and 10. Shipment visibility. All the mentioned challenges exist in the blood 
supply chain either, and lots of research works have been done in these fields to realize how each 
of these obstacles can be eliminated or at least how its effect could be mitigated.  
Some of the research works try to find a solution that can deal with several challenges at the same 
time. During a midterm planning horizon, and by considering a robust stochastic approach, 
(Mousazadeh et al, 2015) suggested a mathematical model to reach tactical decisions about the 
location-allocation problems of a pharmaceutical supply chain network. During the decision phase, 
it has been considered that both total costs and unsatisfied demands should be minimized in order 
to improve the supply chain performance in order management, warehouse management and 
expiration fields. 
From a technological perspective, it has been discovered that pharmaceutical supply chains are 
more production-centric rather than patient-centric delivery models. This issue can be recognized 
as a major problem because the first and foremost important goal of any pharmaceutical supply 
chain is to increase its responsiveness toward the patients. Thus, all the obstacles that exist in this 
field should be identified and eliminated in order to be able to improve the performance. (Settanni 
et al, 2017) employed a various range of operation research methods and understood four main 
challenges that should be removed from the pharmaceutical supply chain network to be more 
practical in today’s world.  
Due to the high complexity of the pharmaceutical inventory management, pharmaceutical 




a mathematical framework which is a guideline to take all the ordering and inventory decisions at 
the operational, tactical and strategic levels. In the framework, the operational decisions focused 
on the reorder point and order up to level issues, while the tactical decisions tried to find the best 
balance between three key performance indicators that are: the expected number of daily refill 
workloads, the service level and the storage space utilization. The strategic decision provided the 
most appropriate condition for both operational and tactical decisions. 
In every pharmaceutical supply chain, time, quality and cost are three main factors that are in a 
direct relationship with customers’ satisfaction. (Imran et al, 2018) called these three factors in 
their paper “Business Triad”. By considering the fuzzy programming method, a mathematical 
model has been suggested to minimize all the related complaints to the business triad. The 
proposed model tried to offer customer satisfaction as another perspective that has a direct impact 
on the performance of a pharmaceutical supply chain.  
From hospitals’ point of view that are the main consumer of blood components, there are various 
factors that affect the delivery time of blood components, and besides all the internal factors that 
have an effect on the inventory management, setting an optimized ordering policy for the hospitals 
depend on these factors as well. (Uthayakumar and Priyan, 2013) developed a pharmaceutical 
supply chain model in which various aspects such as multiple products, variable lead time, 
permissible payment delays and constraints on space availability have been considered in order to 
find the optimal way which led to both reducing the costs and improving the customer service 
level. The proposed solution can be applied to any blood supply chain either because the blood 
network is one example of a pharmaceutical network, and any circumstance that exists in a 




2.10. Blood as a Cold Fresh Product 
Figure 1.6 shows that each of the blood components needs its own temperature setting to be 
transformed. Hence, the blood supply chain for some of the components like RBCs, and plasma 
should be considered as a cold supply chain either, and follow all the necessary procedures. (Chen 
et al, 2014) described the cold supply chain as a supply chain that usually is used for perishable 
items like blood during their storage, transport and sales in order to keep them fresh. Hence, it can 
be realized that one of the main concerns that exist regarding cold blood supply chains is about the 
freshness of the perishable items which determines whether they are safe to use or not. The 
inefficient results in the identification and tracking of blood products have been improved by using 
the RFID tags. (Chen et al, 2014) proposed a Refined Smart Cold Chain System (RSCCS) method 
which is equipped with RFID tags) in order to provide all the necessary information for both 
suppliers and customers to be sure about the safety and freshness of the perishable products which 
are delivered through a cold supply chain. Furthermore, (Coustasse et al, 2013) presented the 
application of RFID technology in the hospitals to improve patients’ safety. Based on the results, 
it has been discovered that applying RFID tags in the blood supply chain framework not only 
decreases the cost dramatically, but also does it increase the ability to track and locate blood 
components. (Due to Davis et al, 2009) research work, it has been discovered that the RFID 
application process can recoup investment cost in a 4-year payback period. 
Moreover, it also should be noted that any changes related to the time or temperature of a supply 
chain can cause an increase in the net present value of the cold supply chain. In the real world, 
various types of perturbation exist which leads to negative effects on the supply chain performance. 
(Bogataj et al, 2005) proposed a mathematical method in which the factors which cause the 




different situation understanding the perturbations that exist in the real world, and the ways which 
can mitigate the former’s harmful effects can be helpful to create a flexible blood supply chain. 
Time Sensitivity is one of the main factors that managers would consider when they want to have 
a precise plan for perishable items. Transportation time and inventory levels are the main items 
that are in a direct relationship with time sensitivity, and any improvement in these items can 
mitigate the sensitivity dramatically. During the past few years, various options have been 
proposed for facing this issue. (Musavi and Bozorgi, 2017) suggested a sustainable hub location-
vehicle scheduling model in order to find an optimal solution that improves both reliability and 
efficiency. Based on the results, it can be realized that establishing several hubs across a specific 
region can help to improve blood transfusion performance. That is why, some of the hospitals and 
clinical centers may be far from the blood collection centers, hence, considering an intermediate 
center that can store a specific amount of blood would be useful to overcome both shortage and 





Tables 2.1 to 2.5 demonstrate a summary of most related papers to this study and existing gaps of the current 
research works. 
Table 2.1- Literature Review Summary 
No. Author(s) Publication Year 




Red Blood Cells Platelets Case Study Numerical Example 
1 Blake et al 2003 ●    ● ●  
2 Kopach et al 2003 ●  ●   ●  
3 Dijk et al 2009 ●  ●  ● ●  
4 Fontaine et al 2009 ●    ● ●  
5 Ghandforoush & Sen 2010 ●    ●  ● 
6 Fontaine et al 2010 ●   ●  ●  
7 Hemmelmayr et al 2010  ● ●    ● 
8 Nagurney et al 2012  ● ●    ● 
9 Nagurney & Masoumi 2012  ● ●    ● 
10 Abdulwahab & Wahab 2014  ● ●  ● ●  
11 Duan & Liao 2014  ●  ●   ● 
12 Zahiri et al 2015 ●  ●   ●  
13 Sahinyazam et al 2015  ● ●   ●  
14 Civelek et al 2015 ●    ●  ● 
15 Rutherford et al 2016 ●  ● ●  ●  
16 Najafi et al 2017  ● ●    ● 
17 Kaveh & Ghobadi 2017 ●  ●   ● ● 
18 Lowalekar & Ravi 2017 ●  ●   ●  
19 Fahimnia et al 2017  ● ●    ● 
20 Zahiri et al 2017  ● ●   ●  
21 Habibi et al 2018  ● ●   ●  
22 Eskandari et al 2018  ●   ●  ● 
23 Jafarkhan & Yaghoubi 2018 ●   ●  ●  
24 Ekici et al 2018  ● ●    ● 
25 Zahiri et al 2018  ● ●    ● 
26 Larimi et al 2019  ●   ● ●  
27 Rjandran & Rayindran 2019 ●    ●  ● 
28 Dehghani et al 2019 ●  ●   ● ● 
29 Hamdan & Diabat 2019  ●  ●  ●  





Table 2.2- Literature Review Summary 
No. Author(s) Publication Year 
Approach Optimization Model 
Simulation Optimization Decision Making Analysis Linear Non-Linear 
1 Blake et al 2003 ● ●   ●  
2 Kopach et al 2003 ●      
3 Dijk et al 2009 ● ●   ●  
4 Fontaine et al 2009    ●   
5 Ghandforoush & Sen 2010  ● ●   ● 
6 Fontaine et al 2010 ●   ●   
7 Hemmelmayr et al 2010  ●   ●  
8 Nagurney et al 2012  ●   ●  
9 Nagurney & Masoumi 2012  ●   ●  
10 Abdulwahab & Wahab 2014 ● ●    ● 
11 Duan & Liao 2014 ● ●    ● 
12 Zahiri et al 2015  ●   ●  
13 Sahinyazam et al 2015  ●   ●  
14 Civelek et al 2015  ● ●  ●  
15 Rutherford et al 2016 ●      
16 Najafi et al  2017  ●    ● 
17 Kaveh & Ghobadi 2017  ●   ●  
18 Lowalekar & Ravi 2017   ●    
19 Fahimnia et al 2017  ●   ●  
20 Zahiri et al 2017  ●   ●  
21 Habibi et al 2018  ●   ●  
22 Eskandari et al 2018  ●    ● 
23 Jafarkhan & Yaghoubi 2018  ●   ●  
24 Ekici et al 2018  ●   ●  
25 Zahiri et al 2018  ●    ● 
26 Larimi et al 2019 ● ●   ●  
27 Rjandran & Rayindran 2019  ●   ●  
28 Dehghani et al 2019 ● ●   ●  
29 Hamdan & Diabat 2019  ●   ●  









Table 2.3- Literature Review Summary  
No. Author(s) Publication Year 
Solution Condition 
Heuristic Metaheuristic Exact Normal Emergency 
1 Blake et al 2003   ● ●  
2 Kopach et al 2003   ● ●  
3 Dijk et al 2009  ●  ●  
4 Fontaine et al 2009   ● ●  
5 Ghandforoush & Sen 2010 ●   ●  
6 Fontaine et al 2010 ●   ●  
7 Hemmelmayr et al 2010  ●  ●  
8 Nagurney et al 2012 ●   ●  
9 Nagurney & Masoumi 2012 ●   ●  
10 Abdulwahab & Wahab 2014 ●   ●  
11 Duan & Liao 2014  ●  ●  
12 Zahiri et al 2015   ● ●  
13 Sahinyazam et al 2015  ●   ● 
14 Civelek et al 2015 ●   ●  
15 Rutherford et al 2016   ● ●  
16 Najafi et al  2017   ● ●  
17 Kaveh & Ghobadi 2017  ●  ●  
18 Lowalekar & Ravi 2017   ● ●  
19 Fahimnia et al 2017 ●    ● 
20 Zahiri et al 2017   ● ●  
21 Habibi et al 2018 
  ●  ● 
 
22 Eskandari et al 2018  ●   ● 
23 Jafarkhan & Yaghoubi 2018 ●   ●  
24 Ekici et al 2018   ● ●  
25 Zahiri et al 2018  ●   ● 
26 Larimi et al 2019   ● ●  
27 Rjandran & Rayindran 2019  ●  ●  
28 Dehghani et al 2019 ●   ●  
29 Hamdan & Diabat 2019   ● ●  








Table 2.4- Literature Review Summary 
No. Author(s) Publication Year 
State Delivery 
Certain Uncertain Direct Emergency Lateral 
Stochastic Fuzzy Robust External Reactive Proactive 
1 Blake et al 2003  ●   ●    
2 Kopach et al 2003  ●   ●    
3 Dijk et al 2009 ●    ●    
4 Fontaine et al 2009 ●        
5 Ghandforoush & Sen 2010 ●    ●    
6 Fontaine et al 2010  ●   ●    
7 Hemmelmayr et al 2010  ●  ● ●    
8 Nagurney et al 2012 ●    ●    
9 Nagurney & Masoumi 2012 ●    ●    
10 Abdulwahab & Wahab 2014 ●    ●    
11 Duan & Liao 2014 ●    ●    
12 Zahiri et al 2015   ● ● ●    
13 Sahinyazam et al 2015 ●    ●    
14 Civelek et al 2015 ●    ●    
15 Rutherford et al 2016 ●    ●    
16 Najafi et al  2017  ●   ●    
17 Kaveh & Ghobadi 2017 ●    ●    
18 Lowalekar & Ravi 2017 ●    ●    
19 Fahimnia et al 2017 ●     ●   
20 Zahiri et al 2017   ● ● ●    
21 Habibi et al 2018 
  
● 
 ● ●    
22 Eskandari et al 2018  ●  ● ●    
23 Jafarkhan & Yaghoubi 2018  ●  ● ●    
24 Ekici et al 2018 ●    ●    
25 Zahiri et al 2018  ● ●  ●    
26 Larimi et al 2019  ●  ● ●  ●  
27 Rjandran & Rayindran 2019  ●   ●    
28 Dehghani et al 2019  ●   ●   ● 
29 Hamdan & Diabat 2019  ●   ●    




After conducting the literature review, it has been realized that the available analytical supply chain 
models usually do not consider the following issues: 
• Hospitals’ connection (Lateral Transshipment Approach) 
• Mobile collection centers during a normal situation 
• Availability of various transportation modes and their specific planning 
• Emergency ordering option from centers in a different stage 
• The effect of test results and existing environmental errors on the amount of collected blood 
units 
• Managing both outdated units’ and shortage problems at the same time 
Hence, by realizing the current gaps, this research aims to propose a mathematical model that can 







BLOOD SUPPLY CHAIN MATHEMATICAL MODEL 
3.1. General Aim 
Increasing the surplus is the main goal of every supply chain (Chopra and Meindl, 2016). Since in 
most countries blood donation is a voluntary process, a blood supply chain network will usually 
be recognized as a non-profitable supply chain. Hence, the blood supply chain network can 
increase its surplus only by decreasing all the related costs. This study aims to discover the actors 
of a blood supply chain network, and redesign the blood supply chain that to only increase the 
surplus, but also improve the performance by taking required actions to reduce shortage rate and 
outdated units’ amount.  
3.2. Design of Supply Chain 
3.2.1. Structure 
The blood supply chain structure includes the following stages: 
1. Donors (Supplier) 
2. Temporary and Permanent Blood Centers (Manufacturer and Distributor) 
3. Hospitals (Retailer) 
4. Patients (Customer) 
Blood components (e.g. RBCs, platelets and plasma) are the main products of a blood supply chain, 
and all the details about the inventory level of these components and their distribution will be 
considered as the information flow of the blood supply chain. Donors are the first stage of every 




manufacturers and distributors. After testing and processing the donated blood in these centers, 
they will distribute the blood components to the hospitals based on the latter demands. Hospitals 
have their own inventory for each blood component, and they are in a direct relationship with 
patients who are the customers of blood components. The stored blood components in the hospitals 
will either be transfused to the patients or be discarded due to their perishable nature.  
Both blood centers and hospitals constantly update their product flows by monitoring the available 
information flow. 
3.2.2. Objectives 
Considering several perspectives during a supply chain design process will help to figure out how 
main objectives of the network should be defined. This research aims to improve both efficiency 
and performance of the blood supply chain. Efficiency is one of the main aspects of every supply 
chain. In this study, redesigning a blood supply chain that its main goal is to reduce all the related 
costs of actors and their interactions, helps to improve the blood supply chain’s efficiency. 
Moreover, by reducing the shortage and outdated units’ rates, the performance level of the 
proposed supply chain network will be improved. 
3.2.3. Process 
Usually, the blood donation process takes between eight to ten minutes. After collecting the blood 
from donors, it will be tested to make sure that it is safe for any further transfusion. Testing process 
has its own lead-time. The tested blood can either be stored as a whole blood or as blood 
components such as, for example red blood cells, platelets and plasma. The processed blood 
components can either be stored in the blood centers or the hospitals. It is noteworthy to mention 
that each blood component has its own storing condition that should be considered in the blood 




depends on the situation, and the delivery time can be varied between normal and emergency 
situations. Blood centers and hospitals always monitor their inventory to discard outdated blood 
units. In situations that patients do not need blood components with specific age, hospitals try to 
use the older blood components in order to decrease the discarding rate. 
3.2.4. Technology 
Monitoring the inventory levels of the supply chain’s actors by applying a suitable technology will 
help the network to increase its efficiency by reducing shortage and discarded units’ rates. The 
applied technology constantly monitors both information and product flows to not only improve 
efficiency and performance, but also to save more lives. 
3.3. The Purpose of the Study 
By considering all the previous research efforts, and available statistics and information, it can be 
realized that improving blood supply chain management not only help responsible organizations 
to improve their performance and reduce costs, but also it helps to save more humans’ lives. Hence, 
the importance of establishing an integrated blood supply chain in which all the activities aim to 
help more people is undeniable. Moreover, (Williamson and Devine, 2013) in their research work 
observed that demands for blood components are growing dramatically, and this increasing rate 
makes blood as one of the most crucial and complicated supply components that exist in today’s 
world. Perishability of blood products, uncertainty in donation and demand sizes are the three main 
reasons that make the blood supply chain planning so challenging. This research aims to develop 




perishable nature of blood units, is a source of risks of shortage and expiration. Hence, an 
integrated supply chain, in which almost all the active actors are considered and organized, can be 
a great help in order to manage blood unit delivery in a way that both hospitals’ satisfaction from 
overcoming shortage and expiration issues will be maximized and costs will be reduced. The 
proposed blood supply chain in this research consists of 3 stages: 
1. Mobile Collection Centers 
2. Blood Centers 
3. Hospitals 
The supply chain begins with mobile collection centers where blood units are collected. Since 
mobile centers are not able to test, process and store the blood units, they send all the collected 
units to the blood center at the end of each period. After receiving the blood units, blood centers 
test a specific percentage of these units to make sure that they are healthy and transferable. The 
testing process always takes one day. When the testing process confirms the blood units’ health, 
they can be stored in the blood centers’ inventory. In order to make the model closer to the real 
world, it has been assumed that some parts of blood units will be discarded due to test results, and 
environmental risk factors such as staffs’ mistakes and device failure. The last stage of the 
proposed supply chain consists of hospitals that determine blood units’ demand in each period. 
Due to demand uncertainty, hospitals can face with shortage, hence, lateral transshipment has been 
considered as a helpful tool in order to deliver blood units from other hospitals to the hospital that 




also send blood units to hospitals that are facing shortage. Blood centers are also responsible for 
delivering fresh blood units to the hospitals based on the lateral orders. The number of orders will 
be determined by considering the desired inventory level, and the existing amount of inventory 
level of each hospital. Both hospitals and blood centers can store blood units with various ages, 
but orders just include fresh blood units that are just received from blood collection centers. The 
lead time of ordering process is one day, and hospitals receive fresh blood units the day after their 
orders take place. Moreover, demand uncertainty can also cause having outdated units in both 
blood centers’ and hospitals’ inventory, thus, discarding option with its own specific cost is 
available in both stages. To reduce the expired amount, it has been assumed that patients can 
receive blood units of any age, and there is no difference between young and old blood units for 
the transfusion process. Furthermore, to make the model more realistic, various transportation 
modes have been considered in the model, which each of them has its own pace and cost. 
3.4. Research Methods 
For redesigning the blood supply chain in this study, two research methods have been used: 
1. Mathematical Optimization Method: This method is one of the most common methods in the 
supply chain field, and it has been selected for implementing in this study because it provides a 




can be obtained when there are various constraints that not only limit the solution area, but also 
have conflict between themselves that even make the situation infeasible.  
2. Applying Case Study: This approach is used in this research work to show how proposed model 
can improve a real-world blood supply chain.  
First by considering the optimization approach, a deterministic single objective mathematical 
model has been proposed in order to both reduce all the related costs and find the best policy to 
reduce both existing shortage and outdated units’ rates. In the next step, the proposed model has 
been applied for a specific case study to be able to provide all the necessary information and data. 
The Greater Toronto Area (GTA) located in the Ontario province of Canada has been selected for 
this research. The required information and data of this study have been collated from considering 
multiple past research efforts and reports. In the end, the proposed model which has been coded in 
the GAMS software was be solved by applying all the gathered data in order to analyze how the 
model would improve the supply chain’s performance, and develop potential practical strategies.  
3.5. Problem Statement 
The blood supply chain can be considered as one of the key actors of any healthcare supply chain. 
The blood supply chain of this research consists of three main stages, as explained in section 3.3. 





•  Given that blood components’ demands are unpredictable; shortage is allowed in the 
hospitals. Lateral transshipment between hospitals and emergency orders from blood 
centers would satisfy the shortage amount (Equations 3 and 4). 
• A specific amount of shortage should be covered in each period of time by applying both 
lateral transshipment approach and emergency delivery from blood centers (Equations 21 
and 22). 
• Each mobile collection center and blood collection center has a limited capacity for 
collecting blood from blood donors in each period of time (Equations 23 and 44).  
• By considering the existing inventory level and the amount of demands, it would be decided 
to whether open a mobile collection center at a specific period or not (Equations 44 and 45). 
• Given that blood is a life-saving product, both hospitals and blood centers are allowed to 
have inventory levels. Hence, both centers are allowed to discard the outdated units 
(Equations 13 and 15). 
• The target inventory of hospitals will be calculated by considering both each period’s 
demand and last period’s shortage (Equations 24 to26). 
• Each hospital’s demand for each period of time has been estimated and specified based on 
existing information and the number of available beds.  
• Only fresh blood components that has 2 days of shelf life would be delivered from blood 
centers to hospitals when the latter order and older blood components will be delivered in 
case of emergency (Equations 3, 8 and 9). 
• The testing process has its own lead-time (Equation 20). 
• Given that environmental risk factors such as test results’ errors, staff errors, etc. exist in 
the blood centers, some parts of collected blood components from both mobile collection 
centers and donors would be discarded (Equation 20). 
• Regular order has its own lead-time (Equation 17). 
• Emergency order has its own lead-time (Equation 3). 
• An initial inventory level for the beginning of the first period of time has been defined for 
each blood center and each hospital (Equations 2 and 10). 
• Given the perishable nature of blood components, the ageing process affects blood 




• To reduce both outdated units’ rate and its related costs, FIFO (First in, First Out) system 
has been applied for the hospitals’ usage (Equations 27 to 43). 
• Although both shortage and discarding outdated units are allowed in hospitals, blood centers 
are not allowed to face any shortage. 
• Several modes of transportation at their own pace, fuel efficiency and planning would be 
available to deliver blood from blood centers to hospitals and between hospitals (Equation 
1). 
• A limited number of each transportation mode would be available in each period of time 
(Equation 46).  
• Figure 3.1 shows the proposed model, consisting of three stages. There are multi mobile 
collection centers that deliver collected blood units to blood centers, blood centers will 
deliver blood units to the hospitals whenever the lateral issues an order, and keep the 
remaining amounts as inventory. Hospitals are the last stage that receives fresh blood units 
from blood centers and requests extra amount in case of shortage from other hospitals, or 
blood centers.  
 




3.6. Mathematical Model 
In this section, the deterministic mathematical model is presented. Notations used in the model 
and their definitions are outlined in Table 3.1. 
Table 3.1- Notations used in the mathematical model 
Sets and Indices 
𝑻 Time Horizon 𝑡𝜖𝑇 R Mobile Collection Centers 𝑟 ∈ 𝑅 
𝑲 Blood centers k𝜖𝐾 
 
𝐼 Hospitals 𝑖, 𝑗 ∈ 𝐼 
𝑴 Remaining shelf life of hospitals’ blood 
units 𝑚𝜖𝑀 
𝑁 Remaining shelf life of blood centers’ 
blood units 𝑛𝜖𝑁 
P Transportation Modes 𝑝 ∈ 𝑃   
Parameters 
𝐵𝑖𝑚
1  Initial inventory of blood units with 
shelf life m at hospital i 
𝑀 Maximum shelf life 
𝐺 Penalty order cost per unit at 
hospitals 
𝐻𝑖 Holding cost per unit at hospital i 
𝐸 Expiry cost per unit at hospitals 𝑆𝐸𝐹 Ordering cost per unit at hospitals 
𝐶𝑖𝑗
𝑚 Cost of transshipping one unit of 
blood with shelf life m from hospital i 
to hospital j 
𝐷𝑖
𝑡 Total demand of hospital i in period t 
𝐶𝐸𝑘𝑖
𝑛  Cost of transshipping one unit of 
blood with shelf life n from blood 
center k to hospital i 
𝑆𝑁𝑘𝑖 Cost of delivering one unit of fresh 
blood from blood center k to hospital i 
𝐻𝐵𝑘 Holding cost at blood center k 𝐶𝑊 Expiry cost per unit at blood centers 
𝑇𝐸𝑆 Testing cost at blood centers 𝐶𝐴𝑃𝑘𝑛
1  Initial inventory of blood units with 
shelf life n at blood center k 
𝛽 Minimum shortage coverage ?́? Very large number 
𝜃 Percentage of blood units which will 
be discarded due to environmental 
risk factors and test results 
HAD Maximum number of open mobile 





𝑍𝐴𝑅𝑟 Capacity of mobile collection center r 𝑀𝐴𝑋𝑝 Maximum number of available 
transportation mode p 
𝑆𝐴𝑁𝑘 Capacity of blood center k for 
donating blood 
𝑉𝐶𝑝 Transportation cost per distance for 
transportation mode p 
𝐿𝐵𝑘𝑖 Distance between blood center k to 
hospital i  






𝑡 Order quantity at hospital i in period 
t  
𝑆𝑖𝑡 Target inventory level of hospital i at 
period t 
𝑖𝑠𝑖𝑚
𝑡  Inventory level of hospital i for blood 
units with shelf life m at the beginning 
of period t 
𝑖𝑒𝑖𝑚
𝑡  Inventory level of hospital i for blood 
units with shelf life m at the end of 
period t 
𝑎𝑖𝑚
𝑡  Quantity of blood unit with shelf life 
m used to fulfil demand at hospital i 
in period t  
𝑓𝑖
𝑡 Quantity of shortage amount at hospital 
i in period t  
𝑉𝑖
𝑡 Total inventory of hospital i at the end 
of period t 
𝜎𝑖
𝑡  Quantity of outdated blood units in 
hospital i at the end of period t  
𝑋𝑖𝑗𝑚
𝑡  Quantity of blood units with shelf life 
m will be delivered from hospital i to 
hospital j in case of shortage in 
period t 
𝐸𝑆𝑘𝑖𝑛
𝑡  Quantity of blood units with shelf life n 
will be delivered from blood center k to 
hospital i in case of shortage in period t 
𝑍𝑘𝑖
𝑡  Quantity of fresh blood units will be 
delivered from blood center k to 
hospital i in period t 
𝐹𝑉𝑘
𝑡 Total inventory of blood center k at the 
end of period t 
𝐷𝑊𝑘
𝑡 Quantity of outdated blood units in 
blood center k at the end of period t  
𝐼𝑛𝑣𝑠𝑘𝑛
𝑡  Inventory level of blood center k for 
blood units with shelf life n at the 
beginning of period t 
𝐼𝑛𝑣𝑒𝑘𝑛
𝑡  Inventory level of blood center k for 
blood units with shelf life n at the end 
of period t 
𝐷𝑂𝑁𝑘
𝑡 Amount of donated blood units at blood 







𝑡  Quantity of delivered blood from 
mobile collection center r to blood 
center k at period t 
𝐸𝑍𝑘
𝑡  The whole emergency blood transferred 
from blood center k in period t 
𝑀𝐼𝑍𝑘𝑛
𝑡  Blood center’s k usage of blood units 




 Binary Variables 
𝑂𝑃𝑟𝑡 If mobile collection center r is open at 
period t 1, otherwise 0 
𝐵𝑇𝐻𝑘𝑖
𝑝𝑡
 If blood center k transfer blood units to 
hospital i by using transportation mode 
p at period t 1, otherwise 0 
𝐻𝑇𝐻𝑖𝑗
𝑝𝑡
 If hospital i to hospital j by using 
transportation mode p at period t 1, 
otherwise 0 
𝑏𝑘𝑛
𝑡  If blood center k uses blood units with 
shelf life n in period t 1, otherwise 0 
𝑔𝑏𝑖𝑚
𝑡  If hospital i uses blood units with shelf 
life m in period t 1, otherwise 0 
  
3.6.1. Objective Function 
The objective of the model is to reduce all related costs which include regular and emergency order 
costs, holding and discarding costs in blood centers, holding, discarding, shortage and ordering 












𝑡 ∗ 𝐻𝐵𝑘 + 𝐷𝑊𝑘
𝑡 ∗ 𝐶𝑊) +
𝑡𝑘





𝑡 ∗ 𝐻𝑖 + 𝜎𝑖
𝑡 ∗ 𝐸 + 𝑓𝑖
𝑡 ∗ 𝐺 + 𝑦𝑖
𝑡 ∗ 𝑆𝐸𝐹)
𝑡𝑖




+ ∑ ∑ ∑ ∑ 𝐵𝑇𝐻𝑘𝑖
𝑝𝑡∗𝑉𝐶𝑝∗𝐿𝐵𝑘𝑖
𝑡𝑝𝑖𝑘






The problem is subject to a variety of constraints that would be mentioned in the following. 
(2) 𝑖𝑠𝑖𝑚
𝑡 = 𝐵𝑖𝑚
1  ∀𝑖, 𝑚, 𝑡 = 1 
Equation (2) indicates that there is a given inventory level for blood units with a specific age at the 
beginning of the first period in each hospital. 
 
(3) 𝑖𝑠𝑖𝑚










𝑡 =  𝑖𝑒𝑖𝑚
𝑡  ∀𝑖, 𝑚, 𝑛 = 𝑚, 𝑡 
Equation (3) sets an equilibrium between initial inventory level and final inventory level of a 










Equation (4) indicates that in each period of time, hospitals may only be able to satisfy a part of 





𝑡  ∀𝑘, 𝑛 ≥ 3, 𝑡 
Equation (5) indicates that in each period of time and in case of shortage, for delivering blood units 
with specific age from a blood center to a hospital, the initial inventory level of the blood center 
for the blood units should be considered since each blood center has a specific capacity in each 





𝑡  ∀𝑘, 𝑛 = 2, 𝑡 
Equation (6) indicates that in each period of time, for delivering fresh blood units from a blood 
center to a hospital the initial inventory level of the blood center for the fresh blood units should 





𝑡  ∀𝑖, 𝑚, 𝑡 
Equation (7) indicates that in each period of time, for transshipping blood units with specific age 
from one hospital to another one, the initial inventory level of the transmitter for the blood units 
should be considered. 
(8) 𝐼𝑛𝑣𝑠𝑘𝑛








Equation (8) sets an equilibrium between initial inventory level and final inventory level of a blood 
center’s blood units which have more than 3 days of shelf life in each period of time. 
(9) 𝐼𝑛𝑣𝑠𝑘𝑛




𝑡  ∀𝑘, 𝑡, 𝑛 = 2 
Equation (9) sets an equilibrium between initial inventory level and final inventory level of a blood 
center’s fresh blood units in each period of time. 
𝐼𝑛𝑣𝑠𝑘𝑛
𝑡 = 𝐶𝑎𝑝𝑘𝑛
1  ∀𝑘, 𝑛, 𝑡 = 1 (10) 
Equation (10) indicates that there is a given inventory level for blood units with a specific age at 
the beginning of the first period in each blood center. 
 𝐼𝑛𝑣𝑒𝑘𝑛
𝑡 = 𝐼𝑛𝑣𝑠𝑘(𝑛+1)
𝑡+1  ∀𝑘, 𝑡 ≠ 𝑇, 𝑛 ≠ 𝑀  (11) 





𝑡  ∀𝑘, 𝑡 (12) 
Equation (12) indicates that in each blood center, by aggregating the final inventory level of blood 
units with various age, the total inventory level of the blood center will be determined. 
𝐷𝑊𝑘
𝑡 = 𝐼𝑛𝑣𝑒𝑘𝑛
𝑡  ∀𝑘, 𝑡, 𝑛 = 𝑀 (13) 
Equation (13) indicates that in each blood center, the final inventory of blood units with M days’ 









Equation (14) indicates that in each hospital, by aggregating the final inventory level of blood units 
with various ages, the total inventory level of the hospital will be determined. 
𝜎𝑖
𝑡 =  𝑖𝑒𝑖𝑚
𝑡  ∀𝑖, 𝑡, 𝑚 = 𝑀 (15) 
Equation (15) indicates that in each hospital, the final inventory of with M days’ shelf life will be 
discarded at the end of each period. 
𝑖𝑒𝑖𝑚
𝑡 = 𝑖𝑠𝑖(𝑚+1)
𝑡+1  ∀𝑖, 𝑡 ≠ 𝑇, 𝑚 ≠ 𝑀 (16) 
Equation (16) indicates the ageing process of stored blood units in a hospital. 
𝑦𝑖
𝑡 = 𝑖𝑠𝑖𝑚
𝑡+1 ∀𝑖, 𝑡, 𝑚 = 3 (17) 
Equation (17) indicates the lead time of delivering orders to a hospital is one day, and orders just 
include fresh blood units.  
 𝑦𝑖
𝑡 = ∑ 𝑍𝑘𝑖
𝑡
𝑘  ∀𝑖, 𝑡 (18) 
Equation (18) indicates that in each period of time, fresh blood units that have been collected from 
all the blood centers will be delivered to each hospital based on its order amount. 




𝑡 ∀𝑖, 𝑡 (19) 
Equation (19) indicates that the number of each hospital’s orders will be determined based on its 










𝑡 ] ∀𝑘, 𝑛 = 2, 𝑡 ≠ 𝑇 (20) 
Equation (20) indicates that it takes one day to test the collected blood units from both mobile 
collection centers and blood centers and to make sure they are safe for future transfusion. It also 




𝑚𝑗≠𝑖 + ∑ ∑ 𝐸𝑆𝑘𝑖𝑛
𝑡
𝑛≥3𝑘 ≥ 𝛽𝑓𝑖
𝑡 ∀𝑖, 𝑡  (21) 




𝑚𝑗≠𝑖 + ∑ ∑ 𝐸𝑆𝑘𝑖𝑛
𝑡
𝑛≥3𝑘 ≤ 𝑓𝑖
𝑡 ∀𝑖, 𝑡  (22) 
Equation (22) indicates that in each period, the received blood units in each hospital should not be 
more than its shortage. 
𝐷𝑜𝑛𝑘
𝑡 ≤ 𝑆𝑎𝑛𝑘  ∀𝑘, 𝑡 (23) 
Equation (23) indicates that in each period and each blood center, the number of collected blood 
units should be less than its capacity. 
𝑆𝑖(𝑡+1) ≤ 𝐷𝑖
𝑡  ∀𝑖, 𝑡 ≠ 𝑇 (24) 
Equation (24) indicates that for reducing the outdated blood units, each period’s demand should 
be considered for planning the next period’s target inventory level. 
𝑆𝑖(𝑡+1) ≥ (1 − 𝛽) ∗ 𝑓𝑖




Equation (25) indicates that by considering each period’s shortage and shortage coverage rate and 
for reducing the shortage rate, the next period’s target inventory level should be more than 
(1 − 𝛽)% of the current shortage. 
𝑆𝑖𝑡 ≥ (1 − 𝛽) ∗ 𝐷𝑖
𝑡  ∀𝑖, 𝑡 ≠ 𝑇 (26) 
Equation (26) indicates that the target inventory level of each period should be more than 





𝑡  ∀𝑘, 𝑡 (27) 
𝑀𝐼𝑍𝑘𝑛
𝑡 ≤ 𝐸𝑍𝑘
𝑡  ∀𝑘, 𝑡, 𝑛 = 𝑀 (28) 
𝑀𝐼𝑍𝑘𝑛
𝑡 ≤ 𝐼𝑛𝑣𝑠𝑘𝑛




𝑡  ∀𝑘, 𝑡, 𝑛 = 𝑀 (30) 
𝐼𝑛𝑣𝑠𝑘𝑛
𝑡 − 𝑀𝐼𝑍𝑘𝑛
𝑡 ≤ ?́?(1 − 𝑏𝑘𝑛




𝑡  ∀𝑘, 𝑡, 3 ≤ 𝑛 ≤ 𝑀 − 1 (32) 
𝑀𝐼𝑍𝑘𝑛
𝑡 ≤ 𝐼𝑛𝑣𝑠𝑘𝑛





𝑡  ∀𝑘, 𝑡, 3 ≤ 𝑛 ≤ 𝑀 − 1 (34) 
𝐼𝑛𝑣𝑠𝑘𝑛
𝑡 − 𝑀𝐼𝑍𝑘𝑛
𝑡 ≤ ?́?(1 − 𝑏𝑘𝑛
𝑡 ) ∀𝑘, 𝑡, 3 ≤ 𝑛 ≤ 𝑀 − 1 (35) 
Equations (27-35) indicate the FIFO system for each period and in each blood center. 
𝑎𝑖𝑚
𝑡 ≤ 𝐷𝑖
𝑡 ∀𝑖, 𝑡, 𝑚 = 𝑀 (36) 
𝑎𝑖𝑚
𝑡 ≤ 𝑖𝑠𝑖𝑚




























𝑡 ≤ ?́?(1 − 𝑔𝑏𝑖𝑚




𝑡  ∀𝑖, 𝑡, 3 ≤ 𝑚 ≤ 𝑀 − 1 (40) 
𝑎𝑖𝑚
𝑡 ≤ 𝑖𝑠𝑖𝑚














𝑡  ∀𝑖, 𝑡, 3 ≤ 𝑚 ≤ 𝑀 − 1 (42) 
𝑖𝑠𝑖𝑚










𝑡 ≤ ?́?(1 − 𝑔𝑏𝑖𝑚
𝑡 ) ∀𝑖, 𝑡, 3 ≤ 𝑚 ≤ 𝑀 − 1, 𝑛 = 𝑚 (43) 




≤ 𝑍𝐴𝑅𝑟 ∗ 𝑂𝑃𝑟𝑡  ∀𝑟, 𝑡 
(44) 
Equation (44) indicates that in each period of time, a mobile collection center can deliver collected 
blood units to all the blood centers only if it would be open in that period of time. 
∑ 𝑂𝑃𝑟𝑡
𝑟
≤ 𝐻𝐴𝐷  ∀𝑡 (45) 
Equation (45) indicates that in each period of time, only a limited number of mobile collection 




+ ∑ ∑ HTHij
pt
𝑗≠𝑖𝑖
≤ MAXp ∀𝑝, 𝑡 
(46) 
 Equation (46) indicates that in each period of time, a limited number of each transportation mode 
would be available to transfer blood units from blood centers to hospitals, and between hospitals. 
 𝑦𝑖




𝑆𝑖 ≥ 0 ∀𝑖  (48) 
𝑖𝑠𝑖𝑚
𝑡 ≥ 0 ∀𝑖, 𝑚, 𝑡  (49) 
 𝑖𝑒𝑖𝑚
𝑡 ≥ 0 ∀𝑖, 𝑚, 𝑡  (50) 
 𝑎𝑖𝑚
𝑡 ≥ 0 ∀𝑖, 𝑚, 𝑡  (51) 
𝑓𝑖
𝑡  ≥ 0 ∀𝑖, 𝑡  (52) 
𝑉𝑖
𝑡 ≥ 0 ∀𝑖, 𝑡  (53) 
𝜎𝑖
𝑡 ≥ 0 ∀𝑖, 𝑡  (54) 
𝑋𝑖𝑗𝑚
𝑡 ≥ 0 ∀𝑖, 𝑗 ≠ 𝑖, 𝑚, 𝑡  (55) 
𝐸𝑆𝑘𝑖𝑛
𝑡 ≥ 0 ∀𝑘, 𝑖, 𝑡, 𝑛  (56) 
𝑍𝑘𝑖
𝑡 ≥ 0 ∀𝑘, 𝑖, 𝑡  (57) 
𝐹𝑉𝑘
𝑡 ≥ 0 ∀𝑘, 𝑡  (58) 
𝐷𝑊𝑘
𝑡 ≥ 0 ∀𝑘, 𝑡  (59) 
𝐼𝑛𝑣𝑠𝑘𝑛
𝑡 ≥ 0 ∀𝑘, 𝑡, 𝑛  (60) 
𝐼𝑛𝑣𝑒𝑘𝑛
𝑡 ≥ 0 ∀𝑘, 𝑡, 𝑛  (61) 
𝐷𝑜𝑛𝑘
𝑡 ≥ 0 ∀𝑘, 𝑡  (62) 
𝐻𝐽𝑀𝑟𝑘
𝑡 ≥ 0 ∀𝑟, 𝑘, 𝑡  (63) 
𝑆𝑎𝑛𝑘 ≥ 0 ∀𝑘  (64) 
𝐸𝑍𝑘
𝑡 ≥ 0 ∀𝑘, 𝑡  (65) 
𝑀𝐼𝑍𝑘𝑛
𝑡 ≥ 0 ∀𝑘, 𝑡, 𝑛  (66) 
𝑏𝑘𝑛
𝑡 𝜖{0,1} ∀𝑘, 𝑛, 𝑡  (67) 
𝑔𝑏𝑖𝑚
𝑡 𝜖{0,1} ∀𝑖, 𝑚, 𝑡  (68) 





𝑝𝑡𝜖{0,1} ∀𝑘, 𝑖, 𝑝, 𝑡  (70) 
𝐻𝑇𝐻𝑖𝑗
𝑝𝑡𝜖{0,1} ∀𝑖, 𝑗 ≠ 𝑖, 𝑝, 𝑡  (71) 
Equations (47-71) indicate the type of decision variables that have been used in the model. 
In the next chapter, the proposed model will be applied to a real-world case study so that its 









As mentioned in Chapter 1, the platelet is one of the blood components which has only 5 days’ shelf 
life, and it has broad range of applications such as, for example surgery, cancer treatments and 
organ transplants. Hence, to both save more lives while increasing system efficiency at the same 
time, this research aims to improve the blood supply chain’s performance and reduce the platelet 
supply chain’s costs. By considering the proposed model in the previous chapter and to be able to 
reach the mentioned goals, the Greater Toronto Area(GTA) has been considered as the case study 
of this research, as a lot of data were publicly available.  
The Greater Toronto Area (GTA) is the most populous metropolitan area in Canada. It consists of 
the central city, Toronto, along with 25 surrounding cities and towns distributed among 
four regional municipalities: Durham, Halton, Peel, and York (OECD Territorial Reviews, 
2010). According to the 2016 census, the Greater Toronto Area has a population of 6,417,516 






Figure 4.1- The map of the GTA (Greater Toronto Area. (2020, January 23). Retrieved from 
https://en.wikipedia.org/wiki/Greater_Toronto_Area) 
In this study, we try to reduce all the related costs of the platelet supply chain in the GTA area 
during a 7 days’ period (a week). In the following, all the necessary information regarding the name 
and location of mobile collection centers, blood centers and hospitals has been presented. In the 
GTA, blood network includes 7 mobile collection centers, 12 blood centers and 20 hospitals are 
operating to realize how the proposed model would behave under a real-world condition. Table A.1 
to A.3 show the information of GTA blood network’s actors. Figures 4.2 to 4.4 demonstrate the 





Figure 4.2- Mobile Collection Centers’ Locations 
 





Figure 4.4- Hospitals’ Locations 
4.2. Demand 
Table A.4 shows hospitals’ demands based on their number of beds. It has been assumed that due 
to the emergency department and surgery operations which exist in each period of time, from 10% 
to 15% of patients in each hospital demand blood units. Moreover, on average, each blood 
transfusion process needs 3 pints of blood units to be injected into patients.  
4.3. Inventory Level 
4.3.1. Hospitals 
Based on the obtained data from Canadian Blood Services, it has been realized that the current 
system is in the amber phase which means each hospital’s inventory level satisfies only 55% to 79 
% of its daily requirement. Hence, due to the first period’s demand in each hospital, Table A.5 
Shows the initial inventory level of blood units with shelf life from 3 to 5 in each hospital. Since, 
the blood units which 3 days’ shelf life are the most desirable units, it has been assumed that 55% 




level contains blood units which 4 days’ shelf life, and 15% of initial inventory level contains 
blood units which 5 days’ shelf life. 
4.3.2. Blood Centers 
Since the main goal of this model is to reduce the shortage level, it has been assumed that the blood 
centers are in the green phase of inventory level which means they can satisfy 80-100% of the 
daily national requirement. Hence, due to the first period’s demand in each hospital, Table A.6 
Shows the initial inventory level of blood units with shelf life from 2 to 5 days in each blood center. 
Since, the blood units which 2 days’ shelf life are the most desirable units, it has been assumed 
that 60% of the initial inventory level contains of blood units which 2 days’ shelf life, 25% of 
initial inventory level contains blood units which 3 days’ shelf life, 10% of initial inventory level 
contains blood units which 4 days’ shelf life and 5% of initial inventory level contains blood units 
which 5 days’ shelf life. 
4.3.3. Mobile Collection Centers 
Mobile collection centers are in the first stage of the proposed supply chain. Each of the existing 
mobile collection centers has its own capacity, Table A.7 shows the capacity of the mobile 
collection center. It has been assumed that in each period of time only 10 mobile collection blood 
centers can be open.  
4.4. Costs 
4.4.1. Hospitals 
Hospitals should order fresh blood units at the beginning of each period. In this problem, it has 




ordered blood units.  Moreover, as it has been mentioned before, if hospitals face with shortage, 
they should order blood units from blood centers and other hospitals to satisfy their needs. In order 
to prevent hospitals from dealing with shortage, it has been assumed that reordering cost is 20% 
more than ordering cost. Hence, the reordering cost for each of the hospitals in this problem is 
equal to $27.24.   
Each hospital has its own holding cost which has been determined based on the size of the hospital. 
(Number of beds). Table A.8 shows the holding cost for each hospital. 
In this study, it has been assumed that expiry cost is 40% less than reordering cost, as blood is a 
vital product, and deals with human lives. Therefore, the expiry cost for all the hospitals in this 
problem is equal to $16.34.  
In this research, it has been assumed that in each period of time, at least 85% of hospitals’ shortage 
should be satisfied. Moreover, since this research aims to reduce both outdated units and shortage 
amounts, if a hospital requests blood units from another hospital, the latter first should send the 
older blood units. Hence, blood units with 5 days’ shelf life have the cheapest transshipping cost. 
Blood units with 4 days’ shelf life are 20% more expensive than blood units with 5 days’ shelf life, 
and blood units with 3 days’ shelf life are 25% more expensive than blood units with 5 days’ shelf 
life. In this problem, it has been assumed that one blood unit with 5 days’ shelf life costs $1.35. 
Moreover, if both hospitals are not in the same region but have a common border, the cost would 
be 10% more than the way that they both are in a same region, and if a blood center and a hospital 
are not in the same region and do not have a common border, the cost would be 15% more than 
the way that they both are in the same region. Table A.9 shows the cost of transshipping one blood 




4.4.2. Blood Centers 
In case of shortage, hospitals can also request blood units from blood centers. Table A.10 shows 
the cost of transshipping one blood unit with its own shelf life from a blood center to a hospital. 
Like hospitals’ transshipping cost, blood units with 5 days’ shelf life have the cheapest blood center 
hospital’s transshipping cost. Blood units with 4 days’ shelf life are 20% more expensive than 
blood units with 5 days’ shelf life, blood units with 3 days’ shelf life are 25% more expensive than 
blood units with 5 days’ shelf life, and blood units with 2 days’ shelf life are 30% more expensive 
than blood units with 5 days’ shelf life. As it has been mentioned earlier, one blood unit with 5 
days’ shelf life costs $1.35. Since in the proposed supply chain, blood centers and hospitals are in 
two different stages, the blood center hospital’s transshipping cost is 20% more expensive than 
hospitals’ transshipping cost. Furthermore, if a blood center and a hospital are not in the same 
region but have a common border, the cost would be 15% more than the way that they both are in 
the same region, and if a blood center and a hospital are not in the same region and do not have a 
common border, the cost would be 25% more than the way that they both are in the same region. 
Blood centers also deliver fresh blood products to the hospital based on their demands. The lead 
time of delivering blood units is one day, and the hospital receives their orders the day after they 
issue the orders. Table A.11 shows the cost of delivering one unit of blood from one blood center 
to one hospital. All the mentioned conditions have an effect on the fresh blood delivery cost as 
well. 
In order to encourage hospitals to increase their own inventory level, it has been assumed that in 
each region, the blood center’s holding cost is 15% more than the average of hospitals’ holding 




Since Blood Centers are the main source of providing blood units, they should always be prepared 
to handle hospitals’ shortage. Therefore, the expiry cost of the blood center is 25% less than the 
expiry cost of the hospital and is equal to $12.25.  
The cost of testing one unit of blood in each blood center would be equal to $ 89.04. 
4.4.3. Mobile Collection Centers 
Mobile collection blood centers deliver fresh blood units to blood centers based on their orders. 
The blood units would be delivered on the same day, but the testing process in blood centers takes 
one day, so in each period, the inventory level of blood centers contains the delivered blood units 
which have been received during the previous period. Table A.13 shows the cost of delivering one 
unit of blood from one mobile blood collection center to one blood center. All the mentioned 
conditions have an effect on the fresh blood delivery cost as well. 
4.4.4. Transportation Modes 
Based on the existing information, it has been realized that cargo vans and trucks are the most 
common transportation modes that are used in the Canadian blood supply chain system. Hence, in 
this problem, Table A.14 shows the vehicles which have been used to distribute blood from blood 
centers to hospitals, and between hospitals: 
By considering the fact that the gas price in GTA area is almost $ 1.179 𝐾𝑚⁄ , and based on the 
fuel efficiency of each vehicle, Table A.15 shows the transshipment cost for each vehicle. 





Tables A.17 and A.18 show the distance between two hospitals and between each blood center and 
each hospital which have been obtained by using Google Maps online service. 
4.6. Risk Factors 
In (Larimi et al, 2019) research work, the platelets’ discarded rate due to the existing risk factors 
and environmental errors can be varied between 5% to 55%. However, since the location of 
proposed case study in this research is different from the location of (Larimi et al, 2019) case study, 
it has been assumed that because of the existing staff errors and environmental risks in the blood 






RESULTS & ANALYSIS 
5.1. Introduction 
This chapter will demonstrate how the proposed model would help the blood supply chain’s actors 
to both reduce their related costs and manage their inventory level. In the next step and by 
considering the obtained results, some sensitivity analysis will be conducted to realize how the 
model would behave if any changes happen in the system. In the last step, a simulation model will 
be adopted to perform validation process in order to make sure that the proposed model is valid 
for any further application.  
5.2. Results 
By considering previous research works and existing information, a base blood supply chain model 
without considering the lateral transshipment approach and emergency ordering option has been 
solved to show how the current situation is. In the next step, both lateral transshipment approach 
and emergency ordering options have been added to the model to demonstrate how these 
approaches will improve the results. Both based and proposed models have been implemented in 
GAMS win32 27.1.0 using Intel ® Core™ i5-2320 CPU 3 GHz processor with 8 GB of RAM. A 











Total Shortage Amount(Units) 
Base Proposed 
16144.70 10746.05 
Percent of Satisfied Demand(%) 
Base Proposed 
53 79 
Total Outdated Units Amount 
Base Proposed 
538 0 
Table 5.2-Summary of the improvements 
Total Costs Improvement 
(%) 
Total Shortage Improvement 
(%) 
Total Discarding Improvement 
(%) 
13 33 100 
The first row of Table 5.1 shows the total costs of both based and proposed model, the next two 
rows show the total shortage amount in each model, and the percentage of satisfied demand in 
each model. The last two row shows the number of outdated units in each model. 
By considering the obtained results, Table 5.2 provides a summary of improvements after applying 




model will decrease the costs by 13%. The next column demonstrate that the total shortage amount 
will reduce by 33% in the proposed model. The last column shows that there would be no wastage 
in the proposed model.  
Figures 5.1 to 5.3 graphically display how the application of lateral transshipment and emergency 
ordering approaches will improve the results of the model. 
 





Figure 5.2- Models’ Total Shortage 
 
Figure 5.3- Models’ Outdated Units 




5.3. Sensitivity Analysis 
The amount of demand, initial inventory level of blood centers and hospitals, risk factor and 
shortage coverage are the parameters that can be changed due to some unforeseen circumstances. 
Hence, this section will show how the final result would change if any unexpected changes happen 
to the mentioned parameters, and how the model should behave in order to deal with these changes. 
5.3.1. Demand 
To realize how the proposed model would behave if the hospitals’ demands change, the demand 
amount has been decreased up to -5% and increased up to +10%. More than 5% decrease or 10% 
increase in the demands’ amount makes the proposed model infeasible. Therefore, it can be 
realized that if abruptly the demands’ amount increase by 15%, the proposed model cannot 
respond, and the shortage amount would not be satisfied. Figure 5.4 shows how the final result 
will change if any changes happen to the demands’ amount. 
 

















The trend of the plot shows that the total cost will increase if the demands’ amount increase. This 
is a normal behavior since the model has to use more resources for satisfying the extra amount of 
demands. 
5.3.2. The First Period’s Inventory Level of Blood Centers  
To realize how the proposed model would behave if the first period’s inventory levels of blood 
centers change, their inventory level has been decreased up to -20% and increased up to 10%. 
Figure 5.5 shows how the final result will change if the blood centers’ initial inventory level 
change. 
 
Figure 5.5- Blood Centers’ First Period’s Inventory Level Sensitivity Analysis 
As Figure 5.5 shows decreasing in the amount of blood centers’ first period’s inventory level will 
increase the total costs. That is why, the system should use other more expensive resources. Figure 
5.5 also demonstrate that due to the existence of lateral transshipment approach the model would 




















It is noteworthy to mention that since blood centers are the main stage that can provide fresh blood 
units for hospitals, they should always have initial inventory level in order to be able to satisfy the 
demands. 
5.3.3. The First Period’s Inventory Level of Hospitals 
 To realize how the proposed model would behave if the first period’s inventory levels of hospitals 
change, their inventory level has been decreased up to -20% and increased up to 20%. Figure 5.6 
shows how the final result will change if the hospitals’ first period’s inventory level change. 
As Figure 5.6 shows decreasing in the amount of hospitals’ first period’s inventory level will 
increase the total costs. That is why, the system should use other resources to satisfy the demand. 
Figure 5.6 also demonstrate that due to the existence of lateral transshipment approach the model 
would not become infeasible even if the first period’s inventory levels of blood centers decrease 
by 20%. 
 






















Although storing blood units in hospitals seems to be costly, Figure 5.7 show that a system with 
having first period’s inventory level is more cost effective than a system with no first period’s 
inventory level in its hospitals. It can be realized from Figure 5.7 that storing first period’ inventory 
level in the hospitals would decrease the total cost of the system by 4%. 
 
Figure 5.7- Hospitals’ First Period’s Inventory Level’s Effect on the Total Costs 
Moreover, Figure 5.8 shows that storing initial inventory level in the hospitals not only reduce the 





Figure 5.8- Hospitals’ First Period’s Inventory Level’s Effect on the Total Shortage Amount 
5.3.4. Risk Factor 
The existing environment can always affect the level of risk factors. Hence, in order to realize how 
any changes in the risk factor would affect the final results, the risk factor of the model has been 
decreased up to -15% and increased up to 15%. Figure 5.9 shows that if the risk level decreases, 
the total costs will decrease too. This is a reasonable result because by decreasing the existing risk 
factor, more blood units would be available for transfusion and the emergency ordering amount 
would decrease. In addition, Figure 5.9 demonstrates that if the risk factor level increases, the 





Figure 5.9- Risk Factor Sensitivity Analysis 
5.3.5. Shortage Coverage  
In order to examine the readiness of the proposed system, its shortage coverage has been decreased 
by up to -15% and increased up to +15%. The current system would satisfy at least 85% of the 
existing shortage, Figure 5.10 shows how the total costs would change if there are any changes in 
the shortage coverage rate. As has been shown in Figure 5.10, by decreasing the shortage coverage 
amount, the total costs would decrease as well. This is because the model is allowed to contain 
more unsatisfied demands. Similarly, by increasing the shortage coverage rate, the total cost would 
increase too, and that is why the model is more forced to satisfy all the existing shortage. Figure 
5.10 also demonstrates that the proposed model can completely satisfy the existing shortage. This 
























Figure 5.10- Shortage Coverage Sensitivity Analysis 
5.4. Validation 
The validation of the proposed model has been obtained by using a simulation approach. In this 
approach, the proposed model has been run for 100 times, and each run’s final result has been 
calculated individually. Based on the obtained results from demand sensitivity analysis, and to run 
the proposed model in this simulation approach, it has been assumed the demand of this simulation 
process has a uniform distribution between -5% and +10% of its primary amount. Table 5.2 shows 
the final result of both the primary model and the simulated model. As has been shown in Table 
5.2, although the final result of the primary model is better than the simulated model, both results 
are really close to each other and the value of the standard deviation is inconsiderable. Hence, by 
considering all these facts, it can be realized that the proposed model is valid. 
Table 5.3-Validation Results 
Final Result($) 
Standard Deviation($) 
Primary Model Simulated Model 


















5.5. Conclusion  
By considering all the obtained information in this chapter, it can be realized that by applying the 
lateral transshipment and emergency ordering approaches, the model’s results will improve and 
both inventory level and related costs will reduce. Moreover, after conducting sensitivity analysis, 
the obtained results demonstrate that although unexpected changes may affect the final result, in 
most cases the proposed model would be able to respond to these changes. This shows that the 
proposed model has enough flexibility to deal with any unexpected shifts. In the end, after 100 
runs, the simulation process demonstrates that the proposed model has validation for any further 










As has been mentioned in Chapter 1, currently, the Canadian blood supply chain buys blood units 
from the US to satisfy both its demand and shortage. In this research, the primary model proposed 
replacing the mentioned approach with using lateral transshipment and emergency ordering 
approaches in order to both save time and costs. Moreover, However, it has been realized that if 
the demand’s amount increases by more than 15%, the proposed model would not be able to satisfy 
the needs. Hence, an updated model by considering buying blood units from the US beside lateral 
transshipment and emergency ordering approaches has been proposed in this chapter. The 
unexpected increasing rate in the demand’s amount can be occurred due to some emergency 
situations. Thus, the updated model has been investigated as both non-profitable and profitable 
models to realize how this external help can affect the Canadian blood supply chain performance. 
6.2. Updated Model 
Considering an external help beside the two previous approaches will aid the system to increase 
its readiness for confronting any unexpected changes. For applying the external help into the 
model, some modifications in the primary proposed model are required. Therefore, this section 
will introduce all the new required parameters and decision variables. It is noteworthy to mention 
that all the previous parameters, decision variables and information that has been shown in Chapter 
3 are going to be used in the updated model as well. Tables 6.1 to 6.3 show both new notations, 




Table 6.1- New notation used in the updated mathematical model 
Sets and Indices 
𝑸 US blood centers 𝑞 ∈ 𝑄 
Table 6.2- New parameters used in the updated mathematical model 
Parameters 
𝐴𝑀𝐶𝐴𝑞𝑛
𝑡  Total inventory of US blood center q for blood units with shelf life n at period t 
𝐻𝑎𝑧𝑛 Cost of delivering one unit of blood with shelf life n from US blood centers to 
hospitals 




𝑛𝑡 The amount of blood units that can be delivered from US blood center q to hospital i 
with shelf life n at period t   
By considering new parameters and the decision variable, the updated model can be generated 
from the primary model. The updated model can be either non-profit or commercial. Due to the 
new circumstances, the objective function and some of the constraints which have been explained 
in Chapter 3 will change to prepare the system for responding to unexpected changes in demand’s 
amount. The following two sections will demonstrate how the primary will change due to the new 
condition.  
6.2.1. Non-Profit Blood Supply Chain 
If during the unexpected changes, US blood centers deliver the blood units with no costs, there 




of blood centers, and the extra amount of blood units that are going to be delivered to the hospitals, 
some constraint of the primary model would change. 
In the updated model, it has been assumed that if hospitals face shortage, they not only could get 
help from blood centers and hospitals, but also can they receive an extra amount of blood units 
from US blood centers. US blood centers can also deliver fresh blood units. Thus, in the updated 
model, hospitals can order fresh blood from both Canadian and US blood centers. However, the 
limited capacity of US blood centers will restrict the delivered amount from these centers to 
hospitals. By considering all the mentioned assumption, it would be realized that equations (18), 
(21) and (22) of Chapter 3 would change. The equations (1-3) are the updated version due to the 
new circumstances.  
𝑦𝑖
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+ ∑ ∑ 𝐸𝑆𝑘𝑖𝑛
𝑡
𝑛≥3𝑘




𝑡    ∀𝑖, 𝑡 (3) 
Equation (1) indicates that in each period of time, hospitals’ orders can be satisfied by both 
Canadian and US blood centers. 
Equations (2) and (3) indicate that the US blood centers can deliver blood directly to the hospitals. 
It should be mentioned that since blood units are delivered from the US, it has been assumed that 





6.2.2. Commercial Blood Supply Chain 
If US blood centers sell their blood units to the Canadian blood supply chain during an unexpected 
change, some additional costs like cost of testing, preparation, storing and delivery will be added 
to the primary model. In this case, not only the mathematical model’s constraints will change, but 
also will the model’s objective function be affected. The constraints of the commercial blood 
supply chain model are the same as the constraints of the non-profit blood supply chain model. 
Hence, in this system, the equations (18), (21) and (22) of Chapter 3 should again be replaced with 
equations (1-3) that have been described in the previous section. Furthermore, the objective 
function of the primary model (equation (1) of Chapter 3) will be replaced with the following 
equation. 
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Equation (4) indicates that besides all the previously mentioned costs, delivering fresh and 
emergency blood units from blood centers to hospitals has its own specific cost which would affect 





In conclusion, it can be realized that delivering an extra amount of blood units from US blood 
centers to the hospitals can be considered as a great help that can assist the latter to deal with any 
abrupt changes. However, since in the commercial supply chain, US blood centers have their costs, 
the Canadian blood supply chain has to consider all aspects to decide whether the extra amount 
should be delivered from US blood centers or some other actions have to be taken. 
6.3. Implementation 
As has been described in Chapter 4, the Greater Toronto Area (GTA), which located in Southern 
Ontario, has been selected as the case study of this research. By considering the location of the 
case study and in order to minimize both travel time and costs, it has been realized that the US 
blood centers that are going to deliver extra blood units should be located in the US states which 
have a common border with Southern Ontario. Therefore, 4 states have been selected, namely 
Michigan (MI), Ohio (OH), Pennsylvania (PA) and New York (NY). Based on the available 
statistic, 37% percent of the US population is eligible to donate blood, and from this population, 
only near 7% donate blood annually. (National Blood Collection, 2007) Regarding the 
demographic analysis of 4 mentioned states, Table B.1 shows the total inventory level of US blood 
centers in each period. It is noteworthy to mention the inventory level of blood units depends on 
their shelf life which is from 2 to 5 days. The fresh blood units with 2 days of shelf life form the 
largest part of the inventory level, and the blood units with 5 days of shelf life have the least part 
of the inventory level.  
Moreover, Table B.2 shows the total cost of transporting one unit of blood with a specific shelf 




processing cost, storing cost and transshipping cost. The total cost has been obtained based on the 
available information. It has been assumed that the total cost would be the same for all the states 
and all periods. 
Table B.2 shows that in order to reduce the outdated units’ amount, as blood units become older, 
their transporting cost becomes cheaper as well. 
6.4. Results and Analysis 
This section aims to demonstrate the results of both mentioned supply chains. Both commercial 
and non-profit models have been implemented in GAMS win32 27.1.0 using Intel ® Core™ i5-
2320 CPU 3 GHz processor with 8 GB of RAM. A summary of the results has been provided in 
Table 6.6. 










Given Table 6.6, it can be realized that if the Canadian blood supply chain wants to buy blood 
units from the US, not only its cost will increase by almost 80%, but also does its purchasing power 
decrease by almost 94%. This is because the cost of buying blood units from US blood centers is 
expensive, and in the commercial blood supply chain, hospitals prefer to choose lateral 
transshipment and emergency ordering from Canadian blood centers approaches over buying 
blood units from the US. On the other hand, based on the results, if the blood units will be delivered 
from the US blood centers with no costs, hospitals would prefer to deliver blood units from US 
blood centers, and store these units in their inventory rather than ordering from other hospitals or 
Canadian blood centers. 
Figures 6.1 and 6.2 show how respectively total costs and delivery amount from US are different 
between Commercial supply chain and Non-Profit Supply Chain. 
 





Figure 6.2- The Amount of Delivered Platelets’ Units from US to Canada 
6.5. Conclusion 
The obtained results and analysis demonstrate that when blood units’ demand increase 
dramatically in an emergency situation, the Canadian blood supply chain should either find a non-
profit organization that can satisfy the extra amount of hospitals’ demand, or allocating a specific 
amount of budget to buy blood units from available US blood centers. Otherwise, adopting a 
commercial blood supply chain system would not be worthy for the Canadian blood supply chain. 
That is why, in a commercial blood supply chain, the cost would increase and the delivered amount 
from US blood centers would decrease greatly. In conclusion, it can be realized that an external 
help during an abrupt change would be useful and satisfy demands, however, it would be a decisive 
decision for Canadian blood supply chain to determine its priorities and set a plan that can assist 





CONCLUSIONS & RECOMMENDATIONS 
7.1. Conclusions 
In this research an integrated blood supply chain framework with adopting a reactive lateral 
transshipment and emergency ordering approaches under a certain condition to reduce the related 
costs and optimize the inventory level has been proposed. Reactive lateral transshipment approach 
allows hospitals to request for extra amount of blood units from other hospitals whenever they face 
with shortage, and emergency ordering option allows blood centers to deliver extra amount of blood 
units to hospitals in case of shortage. Since the existence of humans’ errors is an undeniable fact, a 
specific amount of collected blood units of the proposed supply chain will be discarded due to these 
errors and tests’ results. To eliminate all the unnecessary costs, various transportation modes with 
specific fuel efficiency have been considered to realize how allocation should be in order to both 
satisfy the demands, and prevent units be outdated. Several parameters such as specific capacity, 
travel distance, fuel efficiency, existing errors rate, etc. have been used to improve the model reality. 
The decision variables of the model relate to the inventory level of both blood centers and hospitals, 
the outdated units’ and shortage amounts of hospitals, the outdated units’ amount of blood centers, 
the fresh blood delivery amount, the quantity of transferred blood from hospitals or blood center 
during a shortage, and selecting the location of mobile blood centers. The proposed mathematical 
model has been applied to a real case study (Greater Toronto Area), and platelet as the rarest blood 
component with the least shelf life has been studied in this research. The obtained results reveal 
that by applying two mentioned approaches the shortage amount of Canadian blood supply chain 




outdated units’ amount in the proposed supply chain which means that compared to the current 
situation, the outdated units’ amount will decrease 100%. 
In the next step, the sensitivity of the model to the demand’s amount has been analyzed, and it has 
been figured out that by increasing the demand more than 15%, the proposed model would not be 
able to reach to the optimized solution. Therefore, a further action has been taken to prepare the 
model for any abrupt changes. By considering an external help from US, the infeasibility of the 
model has been solved. Two approaches have been considered in the updated model. In the first 
approach, a non-profit supply chain has been considered to deliver blood units from US to Canada 
while in the second approach, the supply chain would be commercial and there would be a cost for 
delivering blood units from US to Canada. By shifting the supply chain model from non-profit to 
commercial the cost will increase by almost 80% and the delivery amount will decrease by 94%. 
These results shows that how extra costs will affect the final results. In conclusion, it can be realized 
that if any unexpected change happens in the Canadian blood supply chain system, the CBS 
organization either should ask for non-profit donation or find a way in which buying blood 
components from outside resource would be more cost-effective than lateral transshipment and 
storing blood approaches. 
7.2. Recommendations 
The proposed model of this study can be extended from various perspective. The following actions 




7.2.1. Uncertainty  
Uncertainty is an inseparable part of any system. For future research works uncertainty in demand 
amount and costs can be considered in the model in order to realize how fluctuations would affect 
the final results. 
7.2.2. Patients’ Condition 
Patients’ condition will be determined by considering several factors such as the type of disease, 
the amount of needed blood units, the type of needed blood units. Applying patients’ condition in 
the model can have effect on hospital demand and the amounts of shortage and outdated units. 
7.2.3. Transportation Modes’ Capacity 
Limited capacity of transportation modes can affect both the costs and the amount of delivered 
amount between two centers. Moreover, considering a specific capacity for transportation mode 
will affect the selection of these modes for travelling between two centers. It should also be noted 
that delivering blood components requires specific packaging process in order to provide the 
appropriate storage condition. Figure 7.1 shows various packages which are used by CBS for 




Figure 7.1 - Various Packages for blood components (Receipt of products:  
https://blood.ca/en/hospital-services/inventory-ordering/receipt-products) 
7.2.4. Monitoring Travel Time 
Today’s world technology provides a situation in which everything can be monitored online. 
Applying this technology in proposed model to monitor travel time will make the system closer to 
the real-world situation. This application will change the costs and delivery blood units’ amount of 
the supply chain. 
7.2.5. Enterprise Resource Planning System(ERP)  
ERP system is an integrated system that manage a business process by using software and recent 
technology. The proposed model creates a framework in which an ERP system can be applied for 
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Table A.1- Mobile collection centers’ information 
No. Location Address 
1 Canadian Mar Thorma Church 
(York Region) 
159 Sandiford Dr., Stouffville, ON 
2 Uxbridge Seniors’ Center 
(Durham Region) 
75 Marietta Street, Uxbridge, ON 
3 Holiday Inn Express & Suites, Newmarket. 
(York Region) 
100 Pony Dr, Newmarket, ON 
4 East Gwillimbury Sports Complex 
(York Region) 
1914B Mount Albert Road, Sharon, ON 
5 The Church St. Patrick-Markham 
(York Region) 
5633 Highway #7 East, Markham, ON 
6 Aurora Region 
(York Region) 
105 Industrial Parkway North, Aurora, ON 
7 Newmarket Community Center 
(York Region) 
200 Doug Duncan Drive (formerly 221 Cedar St.), 
Newmarket, ON 
8 Scugog Community Center 
(Durham Region) 
1655 Reach Street, Port Perry, ON 
9 St. Thomas’ Anglican Church 
(Durham Region) 
101 Winchester Rd. E., Brooklin, ON 
10 York Region Administrative Center 
(York Region) 
17250 Young Street, Newmarket, ON 
11 Pickering Recreation Complex- East Salon 
(Durham Region) 
1867 Valley Farm Rd, Pickering, ON 
12 Markham Convention Center 
(York Region) 








Table A.2-Hospitals’ information 
No. Location Address 
1 Credit Valley Hospital Site 2200 Eglinton Avenue West, Mississauga, ON 
2 Halton Healthcare Services Corporation 3001 Hospital Drive, Oakville, ON 
3 Hospital for Sick Children  555 University Avenue, Toronto, ON 
4 Brampton Civic Hospital Site 2100 Bovaird Drive East, Brampton, ON 
5 Joseph Brant Hospital 1245 Lakeshore Rd, Burlington, ON 
6 MacKenzie Health 10 Trench Street, Richmond Hill, ON 
7 Markham-Stouffville Hospital 381 Church Street, P.O. Box 1800, Markham, ON 
8 The Cottage Hospital Site 4 Campbell Dr., Uxbridge, ON 
9 Southlake Regional Health Centre 596 Davis Drive, Newmarket, ON 
10 Etobicoke General Site 101 Humber College Blvd, Etobicoke, ON 
11 Lakeridge Health Oshawa 1 Hospital Ct, Oshawa, ON 
12 Toronto General Hospital 200 Elizabeth Street, Toronto, ON 
13 Peel Memorial Centre for Integrated Health and Wellness Site 20 Lynch St., Brampton, ON 
14 Bridgepoint Hospital Site 14 St. Matthews Road, Toronto, ON 
15 Baycrest Hospital 3560 Bathurst Street, Toronto, ON 
16 Mississauga Hospital Site 100 Queensway West, Mississauga, ON 
17 Salvation Army Toronto Grace Hospital 650 Church Street, Toronto, ON 
18 Toronto East Health Network - Michael Garron Hospital 825 Coxwell Avenue, Toronto, ON 
19 Mount Sinai Hospital Site 600 University Avenue, Toronto, ON 






Table A.3- Blood centers’ information 





9350 Young Street, Richmond Hill, ON 
2 
 
Toronto (College Street) 
 
67 College Street, Toronto, ON 
3 Toronto (King Street) 163 King Street West, Main Floor, Toronto, ON 
4 Toronto (Young & Bloor) 2 Bloor Street East, Hudson’s Bay Centre, Toronto, ON 
5 Burlington 
1250 Brant Street, Burlington, ON 
 
6 Mississauga 756 Britannia Rd. West, Unit 2, Mississauga, ON 













Table A.4- Hospitals’ demands 
No. Hospital Number of Beds 
Demand 
t=1 t=2 t=3 t=4 t=5 t=6 t=7 
1 Credit Valley Hospital Site 382 69 79 62 83 67 74 60 
2 Halton Healthcare Services Corporation 457 83 95 74 99 80 88 71 
3 Hospital For Sick Children 453 82 94 73 99 80 88 71 
4 Brampton Civic Hospital Site 608 110 126 98 132 107 118 95 
5 Joseph Brant Hospital 245 44 51 40 53 43 47 38 
6 MacKenzie Health 506 92 105 82 110 89 98 79 
7 Markham-Stouffville Hospital 309 56 64 50 67 54 60 48 
8 The Cottage Hospital Site 20 4 4 3 4 4 4 3 
9 Southlake Regional Health Centre 400 73 83 65 87 70 77 62 
10 Etobicoke General Site 262 48 54 42 57 46 51 41 
11 Lakeridge Health Oshawa 363 66 75 59 79 64 70 57 
12 Toronto General Hospital 417 76 86 68 91 73 81 65 
13 Peel Memorial Centre for Integrated Health and Wellness Site 367 67 76 59 80 64 71 57 
14 Bridgepoint Hospital Site 464 84 96 75 101 81 90 72 
15 Baycrest Hospital 472 86 98 76 103 83 91 74 
16 Missisauga Hospital Site 751 136 155 122 163 132 145 117 
17 Salvation Army Toronto Grace Hospital 119 22 25 19 26 21 23 19 
18 Toronto East Health Network - Michael Garron Hospital 515 93 107 83 112 90 100 80 
19 Mount Sinai Hospital Site 442 80 91 72 96 78 86 69 
20 West Park Healthcare Centre 314 57 65 51 68 55 61 49 














Table A.5- Hospitals’ initial inventory level for each shelf life 
No. Hospital 
Initial Inventory Level of Each Shelf Life 
Total Initial Inventory Level 
m=3 m=4 m=5 
1 Credit Valley Hospital Site 30 16 8 55 
2 Halton Healthcare Services Corporation 30 16 8 55 
3 Hospital For Sick Children 33 18 9 60 
4 Brampton Civic Hospital Site 44 24 12 80 
5 Joseph Brant Hospital 15 8 4 27 
6 MacKenzie Health 39 21 11 71 
7 Markham-Stouffville Hospital 23 13 6 42 
8 The Cottage Hospital Site 2 1 0 3 
9 Southlake Regional Health Centre 30 16 8 54 
10 Etobicoke General Site 18 10 5 33 
11 Lakeridge Health Oshawa 27 15 7 49 
12 Toronto General Hospital 30 16 8 55 
13 Peel Memorial Centre for Integrated Health and Wellness Site 26 14 7 47 
14 Bridgepoint Hospital Site 34 18 9 61 
15 Baycrest Hospital 33 18 9 60 
16 Missisauga Hospital Site 59 32 16 107 
17 Salvation Army Toronto Grace Hospital 8 4 2 15 
18 Toronto East Health Network - Michael Garron Hospital 40 22 11 73 
19 Mount Sinai Hospital Site 34 18 9 62 













Table A.6- Initial inventory level of blood centers 
No. Blood Centers 
Initial Inventory Level of Each Shelf Life 
Total Initial Inventory Level 
n=2 n=3 n=4 n=5 
1 Richmond Hill Blood Center 244 101 41 20 813 
2 
Toronto Blood Center 
(College St.) 
523 218 87 43 1743 
3 
Toronto Blood Center 
(King St.) 
523 218 87 43 1743 
4 
Toronto Blood Center 
(Yonge & Bloor) 
523 218 87 43 1744 
5 Burlington Blood Center 183 76 31 15 611 
6 Mississauga Blood Center 601 130 105 52 2109 















Table A.7- Mobile collection centers’ capacity 
No Mobile Collection Centers Capacity(Pint of blood) 
1 Canadian Mar Thoma Church. 125 
2 Uxbridge Seniors' Centre 140 
3 Holiday Inn Express & Suites, Newmarket. 125 
4 East Gwillimbury Sports Complex 125 
5 The Church of St. Patrick – Markham 125 
6 Aurora Legion 125 
7 Newmarket Community Centre 125 
8 Scugog Community Centre 140 
9 St. Thomas' Anglican Church 140 
10 York Region Administrative Centre 125 
11 Pickering Recreation Complex - East Salon 140 







Table A.8- Hospitals’ holding cost (Lagerquist et al,2017) 
No. Hospital Holding Cost($) 
1 Credit Valley Hospital Site 21.92 
2 Halton Healthcare Services Corporation 20.18 
3 Hospital For Sick Children 20.27 
4 Brampton Civic Hospital Site 16.67 
5 Joseph Brant Hospital 25.1 
6 MacKenzie Health 19.04 
7 Markham-Stouffville Hospital 23.62 
8 The Cottage Hospital Site 30.34 
9 Southlake Regional Health Centre 21.5 
10 Etobicoke General Site  
11 Lakeridge Health Oshawa 22.36 
12 Toronto General Hospital 21.11 
13 Peel Memorial Centre for Integrated Health and Wellness Site 22.27 
14 Bridgepoint Hospital Site 20.01 
15 Baycrest Hospital 19.83 
16 Mississauga Hospital Site 13.34 
17 Salvation Army Toronto Grace Hospital 28.03 
18 Toronto East Health Network - Michael Garron Hospital 18.83 
19 Mount Sinai Hospital Site 20.53 









Table A.9- Transshipping cost between hospitals (Lagerquist et al,2017) 
No Hospitals 
Hospitals 
Credit Valley Hospital Site Halton Healthcare Services Corporation Hospital For Sick Children 




3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
1 Credit Valley Hospital Site 0 0 0 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
2 Halton Healthcare Services  1.86 1.78 1.49 0 0 0 1.94 1.86 1.55 1.86 1.78 1.49 1.69 1.62 1.35 
3 Hospital For Sick Children 1.86 1.78 1.49 1.94 1.86 1.55 0 0 0 1.86 1.78 1.49 1.94 1.86 1.55 
4 Brampton Civic Hospital Site 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 0 0 0 1.86 1.78 1.49 
5 Joseph Brant Hospital 1.86 1.78 1.49 1.69 1.62 1.35 1.94 1.86 1.55 1.86 1.78 1.49 0 0 0 
6 MacKenzie Health 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 
7 Markham-Stouffville Hospital 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 
8 The Cottage Hospital Site 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 
9 Southlake Regional Health Centre 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 
10 Etobicoke General Site 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 1.94 1.86 1.55 1.94 1.86 1.55 
11 Lakeridge Health Oshawa 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 1.94 1.86 1.55 1.94 1.86 1.55 
12 Toronto General Hospital 1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 
13 
Peel Memorial Centre for Integrated Health 
and Wellness Site 
1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
14 Bridgepoint Hospital Site 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 






Credit Valley Hospital Site Halton Healthcare Services Corporation Hospital For Sick Children 




3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
16 Mississauga Hospital Site 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
17 Salvation Army Toronto Grace Hospital 1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 
18 
Toronto East Health Network - Michael 
Garron Hospital 
1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 
19 Mount Sinai Hospital Site 1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 




MacKenzie Health Markham-Stouffville Hospital The Cottage Hospital Site Southlake Regional Health Centre Etobicoke General Site 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
1 Credit Valley Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 
2 Halton Healthcare Services  1.94 1.86 1.55 1.94 1.86 1.55 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 
3 Hospital For Sick Children 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 
4 Brampton Civic Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 
5 Joseph Brant Hospital 1.94 1.86 1.55 1.94 1.86 1.55 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 
6 MacKenzie Health 0 0 0 1.69 1.62 1.35 1.69 1.62 1.35 1.69 1.62 1.35 1.86 1.78 1.49 
7 Markham-Stouffville Hospital 1.69 1.62 1.35 0 0 0 1.69 1.62 1.35 1.69 1.62 1.35 1.86 1.78 1.49 
8 The Cottage Hospital Site 1.69 1.62 1.35 1.69 1.62 1.35 0 0 0 1.69 1.62 1.35 1.86 1.78 1.49 
9 Southlake Regional Health Centre 1.69 1.62 1.35 1.69 1.62 1.35 1.69 1.62 1.35 0 0 0 1.86 1.78 1.49 
10 Etobicoke General Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 0 0 0 
11 Lakeridge Health Oshawa 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.94 1.86 1.55 
12 Toronto General Hospital 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 
13 Peel Memorial Centre for Integrated Health and Wellness Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 
14 Bridgepoint Hospital Site 1.69 1.62 1.35 1.69 1.62 1.35 1.69 1.62 1.35 1.69 1.62 1.35 1.86 1.78 1.49 
15 Baycrest Hospital 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 
16 Mississauga Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 






MacKenzie Health Markham-Stouffville Hospital The Cottage Hospital Site Southlake Regional Health Centre Etobicoke General Site 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
18 Toronto East Health Network - Michael Garron Hospital 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 
19 Mount Sinai Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 




Lakeridge Health Oshawa 
Toronto General 
Hospital 
Peel Memorial Centre for 
Integrated Health and 
Wellness Site 
Bridgepoint Hospital Site Baycrest Hospital 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
1 Credit Valley Hospital Site 1.94 1.86 1.55 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
2 Halton Healthcare Services 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 1.94 1.86 1.55 1.94 1.86 1.55 
3 Hospital For Sick Children 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 
4 Brampton Civic Hospital Site 1.94 1.86 1.55 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
5 Joseph Brant Hospital 1.94 1.86 1.55 1.94 1.86 1.55 1.86 1.78 1.49 1.94 1.86 1.55 1.94 1.86 1.55 
6 MacKenzie Health 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
7 Markham-Stouffville Hospital 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
8 The Cottage Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
9 Southlake Regional Health Centre 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 
10 Etobicoke General Site 1.94 1.86 1.55 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 
11 Lakeridge Health Oshawa 0 0 0 1.86 1.78 1.49 1.94 1.86 1.55 1.86 1.78 1.49 1.86 1.78 1.49 
12 Toronto General Hospital 1.86 1.78 1.49 0 0 0 1.86 1.78 1.49 1.86 1.78 1.49 1.69 1.62 1.35 
13 Peel Memorial Centre for Integrated Health and Wellness Site 1.94 1.86 1.55 1.86 1.78 1.49 0 0 0 1.86 1.78 1.49 1.86 1.78 1.49 
14 Bridgepoint Hospital Site 1.86 1.78 1.49 1.86 1.78 1.49 1.86 1.78 1.49 0 0 0 1.86 1.78 1.49 
15 Baycrest Hospital 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 0 0 0 
16 Mississauga Hospital Site 1.94 1.86 1.55 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.86 1.78 1.49 






Lakeridge Health Oshawa 
Toronto General 
Hospital 
Peel Memorial Centre for 
Integrated Health and 
Wellness Site 
Bridgepoint Hospital Site Baycrest Hospital 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
18 Toronto East Health Network - Michael Garron Hospital 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 
19 Mount Sinai Hospital Site 1.86 1.78 1.49 1.69 1.62 1.35 1.86 1.78 1.49 1.94 1.86 1.55 1.69 1.62 1.35 




Mississauga Hospital Site 
Salvation Army Toronto Grace 
Hospital 
Toronto East Health Network - 
Michael Garron Hospital 
Mount Sinai Hospital Site West Park Healthcare Centre 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
1 Credit Valley Hospital Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
2 Halton Healthcare Services 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.94 1.86 1.55 1.94 1.86 1.55 
3 Hospital For Sick Children 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.69 1.62 1.35 1.69 1.62 1.35 
4 Brampton Civic Hospital Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
5 Joseph Brant Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.94 1.86 1.55 1.94 1.86 1.55 
6 MacKenzie Health 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
7 Markham-Stouffville Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
8 The Cottage Hospital Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
9 Southlake Regional Health Centre 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
10 Etobicoke General Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
11 Lakeridge Health Oshawa 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
12 Toronto General Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.69 1.62 1.35 1.69 1.62 1.35 
13 Peel Memorial Centre for Integrated Health and Wellness Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
14 Bridgepoint Hospital Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.86 1.78 1.49 1.86 1.78 1.49 
15 Baycrest Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.69 1.62 1.35 1.69 1.62 1.35 






Mississauga Hospital Site 
Salvation Army Toronto Grace 
Hospital 
Toronto East Health Network - 
Michael Garron Hospital 
Mount Sinai Hospital Site West Park Healthcare Centre 
Shelf Life(m) 
3 4 5 3 4 5 3 4 5 3 4 5 3 4 5 
17 Salvation Army Toronto Grace Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.69 1.62 1.35 1.69 1.62 1.35 
18 Toronto East Health Network - Michael Garron Hospital 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.69 1.62 1.35 1.69 1.62 1.35 
19 Mount Sinai Hospital Site 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35 0 0 0 1.69 1.62 1.35 




Table A.10-Transshipping cost between blood centers and hospitals (Lagerquist et al,2017) 





Richmond Hill Blood Center Toronto Blood Center (College St.) Toronto Blood Center (King St) Toronto Blood Center (Young & Bloor) 
Shelf Life(n) 
2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 
1 Credit Valley Hospital Site 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
2 Halton Healthcare Services 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 
3 Hospital For Sick Children 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 
4 Brampton Civic Hospital Site 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
5 Joseph Brant Hospital 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 
6 MacKenzie Health 2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
7 Markham-Stouffville Hospital 2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
8 The Cottage Hospital Site 2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
9 Southlake Regional Health Centre 2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
10 Etobicoke General Site 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
11 Lakeridge Health Oshawa 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
12 Toronto General Hospital 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 









Richmond Hill Blood Center Toronto Blood Center (College St.) Toronto Blood Center (King St) Toronto Blood Center (Young & Bloor) 
Shelf Life(n) 
2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 
14 Bridgepoint Hospital Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 
15 Baycrest Hospital 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 
16 Mississauga Hospital Site 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
17 Salvation Army Toronto Grace Hospital 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 
18 Toronto East Health Network - Michael Garron Hospital 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 
19 Mount Sinai Hospital Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 2.1 2.03 1.94 1.62 










Burlington Blood Center Mississauga Blood Center Oshawa Blood Center 
Shelf Life(n) 
2 3 4 5 2 3 4 5 2 3 4 5 
1 Credit Valley Hospital Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.62 2.54 2.42 2.02 
2 Halton Healthcare Services  2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.62 2.54 2.42 2.02 
3 Hospital For Sick Children 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
4 Brampton Civic Hospital Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.62 2.54 2.42 2.02 
5 Joseph Brant Hospital 2.1 2.03 1.94 1.62 2.41 2.33 2.23 1.86 2.62 2.54 2.42 2.02 
6 MacKenzie Health 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
7 Markham-Stouffville Hospital 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
8 The Cottage Hospital Site 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
9 Southlake Regional Health Centre 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
10 Etobicoke General Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.62 2.54 2.42 2.02 
11 Lakeridge Health Oshawa 2.62 2.54 2.42 2.02 2.62 2.54 2.42 2.02 2.1 2.03 1.94 1.62 
12 Toronto General Hospital 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
13 
Peel Memorial Centre for Integrated Health and 
Wellness Site 
2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.62 2.54 2.42 2.02 
14 Bridgepoint Hospital Site 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 









Burlington Blood Center Mississauga Blood Center Oshawa Blood Center 
Shelf Life(n) 
2 3 4 5 2 3 4 5 2 3 4 5 
16 Mississauga Hospital Site 2.41 2.33 2.23 1.86 2.1 2.03 1.94 1.62 2.62 2.54 2.42 2.02 
17 Salvation Army Toronto Grace Hospital 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
18 
Toronto East Health Network - Michael Garron 
Hospital 
2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 
19 Mount Sinai Hospital Site 2.62 2.54 2.42 2.02 2.41 2.33 2.23 1.86 2.41 2.33 2.23 1.86 







Table A.11- Delivering Fresh Blood Cost from Blood Centers to Hospitals (Lagerquist et al,2017) 




 Blood Center 
Toronto 
Blood Center 
 (College St.) 
Toronto 
 Blood Center 
(King St) 
Toronto 
 Blood Center 







n=2 n=2 n=2 n=2 n=2 n=2 n=2 
1 Credit Valley Hospital Site 2.41 2.41 2.41 2.41 2.41 2.1 2.62 
2 Halton Healthcare Services Corporation 2.62 2.62 2.62 2.62 2.1 2.41 2.62 
3 Hospital For Sick Children 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
4 Brampton Civic Hospital Site 2.41 2.41 2.41 2.41 2.41 2.1 2.62 
5 Joseph Brant Hospital 2.62 2.62 2.62 2.62 2.1 2.41 2.62 








 Blood Center 
Toronto 
Blood Center 
 (College St.) 
Toronto 
 Blood Center 
(King St) 
Toronto 
 Blood Center 







n=2 n=2 n=2 n=2 n=2 n=2 n=2 
7 Markham-Stouffville Hospital 2.1 2.41 2.41 2.41 2.62 2.41 2.41 
8 The Cottage Hospital Site 2.1 2.41 2.41 2.41 2.62 2.41 2.41 
9 Southlake Regional Health Centre 2.1 2.41 2.41 2.41 2.62 2.41 2.41 
10 Etobicoke General Site 2.41 2.41 2.41 2.41 2.41 2.1 2.62 
11 Lakeridge Health Oshawa  2.41 2.41 2.41 2.41 2.62 2.62 2.1 
12 Toronto General Hospital 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
13 Peel Memorial Centre for Integrated Health and Wellness Site 2.41 2.41 2.41 2.41 2.41 2.1 2.62 
14 Bridgepoint Hospital Site 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
15 Baycrest Hospital 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
16 Mississauga Hospital Site 2.41 2.41 2.41 2.41 2.41 2.1 2.62 
17 Salvation Army Toronto Grace Hospital 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
18 Toronto East Health Network - Michael Garron Hospital 2.41 2.1 2.1 2.1 2.62 2.41 2.41 
19 Mount Sinai Hospital Site 2.41 2.1 2.1 2.1 2.62 2.41 2.41 






Table A.12- Blood centers’ holding cost (Lagerquist et al,2017) 
No. Blood Centers Holding Cost($) 
1 Richmond Hill Blood Center 28.18 
2 Toronto Blood Center(College St.) 26.47 




No. Blood Centers Holding Cost($) 
4 Toronto Blood Center(Young & Bloor) 26.47 
5 Burlington Blood Center 26.04 
6 Mississauga Blood Center 22.75 



























 Blood Center 







1 Canadian Mar Thoma Church. 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
2 Uxbridge Seniors' Centre 1.86 1.86 1.86 1.86 2.02 2.02 1.62 
3 Holiday Inn Express & Suites, Newmarket. 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
4 East Gwillimbury Sports Complex 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
5 The Church of St. Patrick – Markham 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
6 Aurora Legion 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
7 Newmarket Community Centre 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
8 Scugog Community Centre 1.86 1.86 1.86 1.86 2.02 2.02 1.62 
9 St. Thomas' Anglican Church 1.86 1.86 1.86 1.86 2.02 2.02 1.62 
10 York Region Administrative Centre 1.62 1.86 1.86 1.86 2.02 1.86 1.86 
11 Pickering Recreation Complex - East Salon 1.86 1.86 1.86 1.86 2.02 2.02 1.62 















 Blood Center 












1 2019 Ford Transit Van 16 
2 2019 Ram Pro-Master Van 15.5 
3 Kenworth T370 14 
Table A.15-Vehicles’ transshipment cost 
No. Name Transshipment Cost ($/Km) 
1 2019 Ford Transit Van 5.77 
2 2019 Ram Pro-Master Van 5.60 
3 Kenworth T370 5.05 
Table A.16- Maximum available number of each vehicle 
No. Name Maximum Available Number 




2 2019 Ram Pro-Master Van 16 








Credit Valley Hospital Site 
Halton Healthcare Services 
Corporation 
Hospital For Sick Children Brampton Civic Hospital Site Joseph Brant 
1 Credit Valley Hospital Site 0 19 35.3 39.7 32.5 
2 Halton Healthcare Services  19.4 0 45.1 48.3 19.9 
3 Hospital For Sick Children 36.2 48.1 0 47.4 59.1 
4 Brampton Civic Hospital Site 30.2 47.8 47.4 0 61.3 
5 Joseph Brant Hospital 33 20.9 59.9 61.8 0 
6 MacKenzie Health 53.3 71.1 40 36.5 84.6 
7 Markham-Stouffville Hospital 68.1 85.9 39.5 51.3 99.4 
8 The Cottage Hospital Site 102 120 73.5 85.2 133 
9 Southlake Regional Health Centre 84.3 102 55.5 67.5 166 
10 Etobicoke General Site 29.6 45.6 30.9 18 66.1 
11 Lakeridge Health Oshawa 89.9 106 63.1 87 135 
12 Toronto General Hospital 36.8 48.6 0.7 47.9 59.5 
13 
Peel Memorial Centre for Integrated Health 
and Wellness Site 
24.6 44 43.6 8.70 53.9 
14 Bridgepoint Hospital Site 45.1 57 3.6 60.8 67.8 
15 Baycrest Hospital 36.4 52.4 10 36.6 65.9 
16 Mississauga Hospital Site 12.3 28.2 24.6 26.6 37.4 
17 Salvation Army Toronto Grace Hospital 44.3 56.2 2.4 60 67.2 
18 
Toronto East Health Network - Michael Garron 
Hospital 







Credit Valley Hospital Site 
Halton Healthcare Services 
Corporation 
Hospital For Sick Children Brampton Civic Hospital Site Joseph Brant 
19 Mount Sinai Hospital Site 36.5 48.3 0.24 47.6 59.4 








MacKenzie Health Markham-Stouffville Hospital 
The Cottage Hospital 
Site 




1 Credit Valley Hospital Site 62.5 66 101 81.8 44.4 
2 Halton Healthcare Services  26.6 85.9 120 101 53 
3 Hospital For Sick Children 29.9 39.4 74.5 55.1 31.9 
4 Brampton Civic Hospital Site 35 49.8 84.3 65.3 16.9 
5 Joseph Brant Hospital 84.6 99.4 133 114 66.6 
6 MacKenzie Health 0 26 45.2 29.5 25.4 
7 Markham-Stouffville Hospital 26.8 0 36.7 42.2 40.2 
8 The Cottage Hospital Site 45.3 37.6 0 30.7 74.1 
9 Southlake Regional Health Centre 30.5 38.7 30.6 0 56.4 
10 Etobicoke General Site 25.4 40.2 74.1 55.1 0 
11 Lakeridge Health Oshawa 59.9 39.4 40 77.9 75.9 
12 Toronto General Hospital 34.7 38.1 72.2 53.3 31.6 
13 
Peel Memorial Centre for Integrated 
Health and Wellness Site 
38.2 53 90.1 67.7 19.9 
14 Bridgepoint Hospital Site 37.1 35.5 71.5 51.9 49.7 
15 Baycrest Hospital 36.7 31.2 67.2 46.8 17.2 
16 Mississauga Hospital Site 49.3 62.3 98 79 20.6 
17 Salvation Army Toronto Grace Hospital 32.6 34.7 70.7 51.1 48.9 
18 
Toronto East Health Network - Michael 
Garron Hospital 
37.7 33.6 67.7 48.2 46 







MacKenzie Health Markham-Stouffville Hospital 
The Cottage Hospital 
Site 















Lakeridge Health Oshawa Toronto General Hospital 
Peel Memorial Centre for Integrated Health and 
Wellness Site 
Bridgepoint Hospital Site Baycrest Hospital 
1 Credit Valley Hospital Site 103 44.2 35.1 46.8 36.1 
2 Halton Healthcare Services  122 48.1 43.8 51 50.8 
3 Hospital For Sick Children 63.2 0.75 43.1 3.2 10.6 
4 
Brampton Civic Hospital 
Site 
86.1 47.4 8.8 50 36.2 
5 Joseph Brant Hospital 120 59.8 57.3 62.7 86 




38.5 39.2 57.6 38.7 31.8 
8 The Cottage Hospital Site 39.1 73.2 91.5 69.8 65.7 
9 
Southlake Regional Health 
Centre 
77.6 55.1 73.8 54.7 47.7 
10 Etobicoke General Site 75.9 30.9 24.3 33.5 18.3 
11 Lakeridge Health Oshawa 0 63.4 93.3 54.3 67.5 
12 Toronto General Hospital 60.9 0 43.4 2.9 10.6 
13 
Peel Memorial Centre for 
Integrated Health and 
Wellness Site 







Lakeridge Health Oshawa Toronto General Hospital 
Peel Memorial Centre for Integrated Health and 
Wellness Site 
Bridgepoint Hospital Site Baycrest Hospital 
14 Bridgepoint Hospital Site 60.2 3 67.1 0 14.3 
15 Baycrest Hospital 55.9 10.6 42.9 14.1 0 
16 Mississauga Hospital Site 83.2 24.5 22.1 27 30.6 
17 
Salvation Army Toronto 
Grace Hospital 
59.4 1.9 66.3 3.9 9.7 
18 
Toronto East Health 
Network - Michael Garron 
Hospital 
56.4 7.7 63.4 5 20.6 
19 Mount Sinai Hospital Site 61.5 0.7 43.7 3.1 11 
20 
West Park Healthcare 
Centre 












Toronto East Health Network - 
Michael Garron Hospital 
Mount Sinai Hospital Site West Park Healthcare Centre 
1 Credit Valley Hospital Site 12.1 37.3 46.1 35.1 27 
2 Halton Healthcare Services  25.9 49.4 58.5 47.5 44.4 
3 Hospital For Sick Children 24.8 2.4 12.9 0.25 17.1 
4 
Brampton Civic Hospital 
Site 
26.3 49 56.5 46.8 29.8 
5 Joseph Brant Hospital 37.6 61.5 70.3 59.8 57.9 




64 37.5 32.4 40 41.8 
8 The Cottage Hospital Site 97.9 71.5 66.3 73.4 75.7 
9 
Southlake Regional Health 
Centre 
80.1 53.5 48.3 55.5 58 











Toronto East Health Network - 
Michael Garron Hospital 
Mount Sinai Hospital Site West Park Healthcare Centre 
11 Lakeridge Health Oshawa 84 60.8 68.1 56.9 77.5 
12 Toronto General Hospital 25.3 1.8 7.5 0.45 17.6 
13 
Peel Memorial Centre for 
Integrated Health and 
Wellness Site 
22.5 45.2 54 42 25.2 
14 Bridgepoint Hospital Site 33.7 3.9 5.3 3 25.9 
15 Baycrest Hospital 30.6 9.8 13.5 10.4 12.3 
16 Mississauga Hospital Site 0 26.3 35.1 23.8 21.4 
17 
Salvation Army Toronto 
Grace Hospital 
32.8 0 6 2.4 12.1 
18 
Toronto East Health 
Network - Michael Garron 
Hospital 
35.1 6 0 7.9 31.3 
19 Mount Sinai Hospital Site 25 2.3 8.2 0 17.3 
20 
West Park Healthcare 
Centre 








Richmond Hill Blood Center 
Toronto Blood Center 
(College St.) 
Toronto Blood Center 
(King St.) 
Toronto Blood Center 
(Young& Bloor) 
Burlington Blood Center Mississauga Blood Center Oshawa Blood Center 
1 Credit Valley Hospital Site 51.1 44.2 33.9 36.8 30.1 8.3 104 
2 Halton Healthcare Services 70.1 48 46.3 49.2 17.5 27.9 123 
3 Hospital For Sick Children 34.2 1 1.6 2.1 55.5 36.4 77.5 
4 Brampton Civic Hospital Site 34.6 47.3 45.6 55.7 58.9 21.4 87.6 
5 Joseph Brant Hospital 83.6 59.8 58.1 68.2 4.3 40.6 137 







Richmond Hill Blood Center 
Toronto Blood Center 
(College St.) 
Toronto Blood Center 
(King St.) 
Toronto Blood Center 
(Young& Bloor) 
Burlington Blood Center Mississauga Blood Center Oshawa Blood Center 
7 Markham-Stouffville Hospital 21.6 38.5 40.6 36.9 97 59.3 39.9 
8 The Cottage Hospital Site 55.6 72.4 74.5 70.8 131 93.2 40.5 
9 Southlake Regional Health Centre 31.4 54.4 56.5 52.8 113 75.5 79.1 
10 Etobicoke General Site 24.4 30.9 29.2 39.3 49.2 21.5 77.4 
11 Lakeridge Health Oshawa 57.4 61.9 63.9 60.3 113 95 5.7 
12 Toronto General Hospital 31.9 0.14 2.5 1.5 55.7 37.1 66.1 
13 
Peel Memorial Centre for 
Integrated Health and Wellness 
Site 
40.2 43.5 41.8 51.9 55.1 17.6 93.3 
14 Bridgepoint Hospital Site 31.2 2.9 4.8 3.9 64.4 45.2 65.4 
15 Baycrest Hospital 15.9 10.2 12.1 9.2 63.4 28.6 61.1 
16 Mississauga Hospital Site 47.4 24.6 22.9 26.6 33.9 10.3 96.1 
17 
Salvation Army Toronto Grace 
Hospital 
30.4 1.6 4.20 0.3 57.4 44.4 64.6 
18 
Toronto East Health Network - 
Michael Garron Hospital 
27.4 7.4 13.2 6.20 65.8 46.6 70.8 
19 Mount Sinai Hospital Site 32.4 0.55 2.10 2 55.8 21.4 68.6 












Time    
1 2 3 4 5 6 7 
Shelf Life(Days) 
2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5 
1 MI 227 124 41 21 205 112 37 19 250 136 45 23 273 149 50 25 307 168 56 28 182 194 33 17 148 81 27 13 
2 OH 266 145 48 24 240 131 44 22 293 160 53 27 319 174 58 29 359 196 65 33 213 127 39 19 173 94 31 16 
3 PA 291 159 53 26 262 143 48 24 320 175 58 29 349 191 64 32 393 214 71 36 233 116 42 21 189 103 34 17 
4 NY 444 242 81 40 400 218 73 36 489 267 89 44 533 291 97 48 600 327 109 55 356 99 65 32 289 158 53 26 
Table B.2- Total Cost of Delivering Blood Units from US to Canada (Forbes, 1991) 
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